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ABSTRACT
SYNTHESIS AND CHARACTERIZATION OF SUGAR BASED LOW MOLECULAR 
WEIGHT GELATORS AND THE PREPARATION OF CHIRAL SULFINAMIDES
Hari Prasad Reddy Mangunuru 
Old Dominion University, 2014 
Director: Dr. Guijun Wang
Low molecular weight gelators (LMWGs) have received considerable attention in the 
field o f chemistry from last few decades. These compounds form self-assembled fibrous 
networks like micelles, cylindrical, sheets, fibers, layers and so on. The fibrous network 
entraps the solvent and forms gel, because o f the self-assembly phenomenon and their 
demonstrated potential uses in a variety o f areas, ranging from environmental to 
medicinal applications.
Sugars are good starting materials to synthesize the new class of LMWG’s, because these 
are different from some expensive materials, these are natural products. We have 
synthesized and characterized the LMGS’s based on D-glucose and D-glucosamine. D- 
glucosamine is the versatile starting material to make different peptoids and triazoles. 
Several series o f compounds were synthesized using compounds 1 -3 as starting material 
and studied the gelation behavior all the compounds.
We have studied the self-assembling properties of a new class o f tripeptoids, 
synthesized by one-pot Ugi reaction from simple starting materials. Among the focused 
library o f tripeptoids synthesized, we found that several efficient low molecular weight 
organogelators were obtained for aqueous DMSO and ethanol mixtures.
We have also synthesized and characterized a series o f monosaccharide triazole 
derivatives. These compounds were synthesized from N-acetyl glucosamine and D- 
glucose via a Cu(I) catalyzed azide/alkyne cycloaddition reaction (CuAAc). The
molecular weight organo/hydro gelators were obtained, among these compounds, five 
per-acetyl glucosamine derivatives and one peracetyl glucose derivative were able to 
form gels in water. These new molecules are expected to be useful in drug delivery and 
tissue engineering.
Asymmetric synthesis o f chiral amines is a challenging in synthetic organic 
chemistry. The development o f  new catalysts for asymmetric organic transformations 
is a very important research goal in modem synthetic organic chemistry. We have 
synthesized a new class o f chiral oxathiozinone from chiral amino phenol. From this 
synthesized chiral sulfinamides, ketimines followed by reducing the ketimines 
synthesized the highly hindered chiral amines.
compounds have been screened for their gelation properties and several efficient low
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CHAPTER 1 
INTRODUCTION TO LMWG’s AND SULFINAMIDES
1.1. INTRODUCTION TO GELATORS
There has been a rapid growth o f  research on low molecular weight gelators (LMWGs), 
because o f  potential applications o f  these materials. An organo/hydrogel is typically 
formed by entrapment o f solvent molecules by the trapped three dimensional self­
assembled fibrillar networks (SAFINs) formed from low molecular weight organo/hydro 
gelators . 1' 4 The supramolecular association are mainly formed due to the weak non 
covalent interactions such as H-bonding, n~n stacking, van der Waal forces, 
donor-acceptor interactions. The formation o f  such an organo/ hydrogel is a thermo 
reversible process as the “gel” can be melted to a “sol” (solution) by heating above a 
characteristic gel melting temperature (Tg). Many researchers are trying to correlate 
properties o f the gels and the structures o f gelators. The chemical structure o f  many 
gelators looks rather diverse, therefore it is difficult to exactly predict the structural 
requirement o f molecules to show gelation. Serendipity is the main reasoning behind gel
c o
formation, which is how many o f the gelators are found during the last few decades. '
Due to the molecular weight difference in polymers and low molecular weight gelators 
these can be categorized in two ways. Polymers attracted much interest because o f  the 
versatility o f  a wide range o f applications. Their use ranges from thermoplastics, 
elastomers, and plastomers as well as thermoplastic elastomers. Polymer gels consist o f  a 
cross-linked polymer network inflated with a solvent such as water. They have the ability
2
to reverse, swell or shrink due to small changes in their environment (pH, temperature, 
electric field, stimuli responses) .9' 10
Polymer based gels have been studied for many years. The advantage o f  these polymer 
gels are strong chemical bonds and mechanical properties. The main disadvantages o f 
polymer hydrogels are they need more gelator (gelator/solvent ratio is relatively high) 
and they are typically thermally irreversible. Figure 1 shows the structures o f two 
polymeric gels . 15' 16
Figure 1. Examples o f  polymer gelators.
The main difference between the polymer gel and low molecular weight gel is the mechanism 
o f gelation. Low molecular weight gelators have been classified based on the self- 
assembly o f  gelator molecules in solvent systems. If the gelator molecules self-assemble 
in the organic solvent those are called organo gelators, where as if  the molecules self- 
assemble in water mediated system those are called hydrogelators. On the other hand, 
polymer gels are assembled based upon their crosslinkage, and solvent entrapment.
1 2
3
1.1.1. LOW M OLECULAR W EIGHT GELATORS
Low molecular weight gelators (LMWGs) are small molecules that can form gel in 
organic solvents and/or water. The gels are mostly liquid trapped in to a three- 
dimensional networks with non covalent interactions such as hydrogen bonding, donor- 
acceptor, n-n 2 hydrophobic and Vander walls interaction’s . 11' 14 Low molecular weight 
gelators are classified into two types, one is organogelators (LM OG’s) and the second 
one is hydrogelators (LM HG’s) . 15'21 There is a big difference in the intermolecular 
interactions o f  these two types. In case o f hydrogelators, they mainly rely on hydrogen 
bonding and hydrophobic interactions and for the organo gelators the main driving force 
is hydrophobic interactions, rather than hydrogen bonding .22
The chemical structure o f many o f  the gelators looks rather simple, it is difficult to 
precisely predict the structural requirements for molecules to show gelation property. 
However, considerable amount o f research has been done so far from many researchers, 
the information gained from a variety o f different types o f gelators helped in rationalizing 
the general structural requirements o f  molecular gelators. These molecules are generally 
showes gelation behavior in presence o f functional groups such as hydroxyl, amide, urea 
and carboxylic acid. These functional groups are capable o f forming hydrogen bonded 
assemblies and they have been proved to be essential for gelation. The general functional 
groups for gelator molecules are shown in Figure 2.
4
O
.H N uA n . '
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Figure 2. General functional group requirements for the design o f  gelators.
The molecules with structural functionality such as amino acids, peptides, peptoids, 
cholesterol, sugar, cyclohexyl, chiral aliphatic/oligiethylene chains have been found to 



















a oNA N -H
h :
Cyclo hexyl Urea
Figure 3. General structures facilitates for the design o f gelators.
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Numerous examples are there for the LM W G’s, researchers are able to find gelators from 
different classes o f compounds including ureas, amides, acids, carbamates, esters, 
carbohydrates, steroids, nucleotides, nucleosides, amino acids, alcohols etc. Some 
examples are shown in Figure 4.
Ph" -̂cr
HN








T O  .«
OH 7
Figure 4. Structures o f  some organo/hydrogelators.
1.1.2. LO W  M O LEC U LA R  W E IG H T  O R G A N O  G EL A T O R S (LM O G s)
There are many reports for the LMOGs, being an important class o f  soft materials, they 
have evolved to be one o f  the most attractive subjects bridging supramolecular chemistry 
and material sciences due to their structural diversity and associated physical properties.
6
M yriad applications in fields such as optoelectronics, light harvesting, environmental 
science, and regenerative medicine are being envisaged .29' 43
Presence o f an aromatic group that helps 7i - 7t stacking is another features for the design 
o f organogelators. Molecules that facilitate dipole-dipole and donor-acceptor 
interactions can also lead to the gelation o f  solvents. These compounds have been around 
for a long time, particularly in lubricants, and the cosmetics industry, where they exist as 
hydrocarbon or fatty acid suspensions. As stated earlier, organogels differ from 
hydrogels, not only by the solvent being gelated, but also by the way the molecules self- 
assemble, which is the main driving force for gelation.
Pyrene Based LM OG’s:
Ziessel et al. reported an efficient organogelator based on the phenylethynyl pyrene 
skeleton comprising o f  amide functional groups .26 The double substitution o f  4- 
ethynylphenylaminoacyl on pyrene renders gel formation in organic solvents such as 
toluene, cyclohexane, and DMF, the bisamide-pyrene compound 8 shown in Figure 5 
was able to form thermally reversible transparent gels with cyclohexane and turbid gels 








Figure 5. Bisamide-pyrene containing organo gelator.
Takashi and Yuko studied the reverse mode fluorescence color switching o f the 
oligopeptide functionalized pyrene gelators shown in Figure 6.29 The cyclohexane gel o f 
pyrene monoglutamate derivatives 9, 10 showed monomer like emission because o f  the 
hydrogen bonded arrays o f  the oligopeptide moieties which suppress the formation o f 
pyrene excimers. The reverse way is encountered in the case o f compound 11 that 
exhibited excimer emission o f pyrene.
R =
11
Figure 6. Structures o f  Pyrene-Containing Oligopeptide Derivatives.
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Azobenzene based LM O G ’s:
Photoresponsive organo gelators have gained considerable attention from last few 
decades. These chromophores are o f  great interest because their properties can be 
modulated using light as an external trigger. For example, upon photo irradiation, gel can 
be transformed into a viscous liquid or a solution. In many cases, the size and shape o f 
the xerogel morphology can be manipulated with light, leading to a change in their 
electronic properties. Such change in photoinduced physical processes can be achieved 
by trans-cis isomerization, 2  + 2  dimerization, photoscission, or photopolymerizations o f 
the chromophore derived gelators.30a‘g Shinkai and co-workers have synthesized many o f 
these azobenzene containing molecules. They made significant contributions to 
azobenzene derived gelators. The two types o f  gelators 12-14 shown in Figure 7 with 
steroid skeletons having either the natural (S) configuration or the inverted (R) 
configuration have been studied. Among them, the gelator with p-alkoxy azobenzene 




J O T " 14
R  = C H 3, C 4 H 9 , C 2 H5, C 10H21, C 3 H 7  
Figure 7. Azobenzene containing steroid molecular organogelators.
Feringa and co-workers have reported chiral recognition in hybrid gel assemblies o f  alkyl 
substituted 1,2-bis-(uriedocyclohexane) derivatives as shown in Fig 8.31a
10
a.lioS< O 'NH
HNv ^ ° H N ^ N X^ H rlO
x-NH
'O
‘  jt  f'a n ^n
16
Figure 8. Azobenzene containing chiral amino molecular organogelators.
Yagai and coworkers developed azobenzene-functionalized diaminopyrimidinone 
derivatives 17 and 18 shown in Figure 9 hierarchically organize into lamellar 
superstructures to form organogels in nonpolar media, which undergo photoinduced 
disruption and reform ation.31c
OC-12H23
Figure 9. Azobenzene containing diaimno pyrimidione organogelators.
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Diacetylene Based LM OG’s:
From last few decades, there has been considerable interest focused in the self-assembly 
study o f diacetylene derivatives. Gel forming diacetylenes are particularly interesting 
because the gel network which is stabilized by the noncovalent interactions can be 
permanently supported by strong covalent bonds.The covalent fixation o f  supramolecular 
assemblies through photo polymerization reactions to give polydiacetylenes, which are 
attractive candidates as conducting nanowires. Kim and his co-workers synthesiszed and 
characterized a series o f polymerization and stabilization o f  the supramolecular 
nanostructures formed by the urethane-amide dendrons 19 and 20 in Fig 10 with 











Figure 10. Diacetylene containing urethane amide dendrons.
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Jean-Francois Morin and his coworkers synthesized a high molecular weight 
polydiacetylenes with low polydispersity index (PI = 1.8) has been achieved in good 
yield from a butadiyne derivative 21 (in Figure 11), having sterically demanding phenyl 




Figure 11. Poly diacetylene containing butadiyne derivatives.
Porphyrine Based LM OG’s:
Porphyrins are a class o f  macrocyclic dyes exhibiting intense absorption bands in the 
visible region and are deeply colored. They have attracted considerable attention in the 
field o f photosynthesis, porphyrins have tunable electronic properties depending on the 
exocyclic modifications and coordinated metal ion. Photosynthetic antenna complexes 
consisting o f self-assembled arrays o f  porphyrinic and carotenoid pigments have been a 
motivation for chemists to design and develop new molecules and assemblies to mimic 
the natural photosynthetic processes.
13
Kimura and his coworkers reported that a mixture o f the zinc porphyrin dimer compound 
23 shown in Figure 12 and an optically active (1R, 2R)-trans-l,2-bis(aklylamide) cyclo-
 ̂1 f
-hexane form an optically transparent gel with well resolved fibrous architecture.
HO
Figure 12. Porphyrin based LMOG’s.
Lazzaroni, De Feyter, Amabilino, and co-workers have investigated the effect o f  the 
number o f stereogenic centers on gelation o f  24 in Fig 13. The interactions between 
molecules were interrupted by the methyl group attached to the stereogenic center that 





Figure 13. Porphyrin based LM OG’s.
Thiophene Based LM OG’s:
From last few decades thiophenes based LM OG’s have attained considerable attention 
because o f their molecular arrangement among large number o f  ^-conjugated systems. 
Due to their high charge carrier mobility and chemical stability, conjugated oligomers 
and polymers o f thiophenes have been used in applications such FETs, LEDs, PVDs, and 
chemical sensors.3111'' Feringa and his coworkers studied the bisurea appended 
oligo(thiophene)s, shown in Figure 14. These molecules were self-assemble in solvents 
such as tetralin and 1, 2-dichloroethane leading to the formation o f organogels.31j
15
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Figure 14. Bis urea appended oligo(thiophene)s LM OG’s.
Samuel and his coworkers designed and synthesized a series o f  phenyl-quater(thiophene), 
ter(phenylene vinylene), and quater(phenylene) segments (Figure 15) as part o f the rod 
segment o f the DRC structure. The self-assembly o f  the conjugated molecules into 
supramolecular ribbon nanostructures leads to enhanced electronic conductivity due to 
improved orbital overlap. Furthermore, these supramolecular polymers can be oriented 
macroscopically in external fields. The iodine doped films were prepared from toluene 
gel exhibited a conductivity value o f  7.9 x 10-5 S cm-1 whereas that o f  the monomer 






Figure 15. Phenyl-quater(thiophene) LM OG’s.
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1.1.3. LOW M OLECULAR W EIGHT HYDRO GELATORS (LMHGs)
Low molecular weight hydrogelators are typically made by dissolving a small amount 
(0.1-20 wt%) o f  the gelator molecule in water and heating until the gelator dissolves. 17 
Rapid cooling o f  heated gelator molecules forms hydrogels after cooling below the sol- 
gel temperature (Tgei). The immobilization o f  the solvent is obtained by the formation o f a 
fibrous network and taking advantage o f w ater’s relatively high external rigidity.32'34 
LMHGs are placed in a different category from their organogelator counterparts 
primarily because o f the biocompatibility, the solvent also causes a different method o f 
association used to assemble with other molecules. When designing LMHGs it becomes 
imperious to control the hydrophobic interactions, which lack the directionality o f 
hydrogen bonding. When a dry hydrogel begins to absorb water, the first water molecule 
entering the matrix will hydrate the most polar, hydrophilic groups, leading to primary 
bound. Once the water molecule is bound to the various interactions with the gelator 
molecule then the gelators become saturated.35
The structure o f hydrogelators mainly consists o f contrasting polar and nonpolar regions, 
in which polar groups mainly include amino acids or sugars, while the nonpolar regions 
mainly include long alkyl chains or aromatic rings. Figure 16 shows the structures o f
”JQ
several compounds (27-30) that can form gels in water.
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Figure 16. Examples o f amphiphilic and bolamphiphilic hydrogelators.
1.1.4. CARBOHYDRATE BASED LMWGs
Carbohydrate based LM W G’s have attracted considerable attention from last few 
decades. The abundance and availability o f these compounds are not the only reason; 
structures o f  these compounds also give people different functional groups to work with. 
These molecules have several hydroxyl groups which are available for introducing other 
functional groups like urea, amide, carbamate.23'24 The hydroxyl groups are very good 
hydrogen bonding donors, which will be useful in gel formation. The presence o f 
multiple chiral centers can be used in the separation o f enantiomers or a heterogeneous 
catalyst used for enantioselective reactions. Carbohydrate based materials are also 
important from medicinal point o f view, because these molecules are natural products
18
and are biocompatible like amino acids. The presence o f  large number o f  hydroxyl group 
in carbohydrates can make the compounds soluble in water.
Shinkai and his coworkers first started glucose, galactose and mannose protected 
monosaccharides at 4, 6 position using benzaldehyde and ZnCl2. The structure o f those 
molecules are shown in Figure 17.40'42
Figure 17. The product o f  a 4,6 position protected sugar.
Shinkai, Hamachi, and the Shimizu groups have produced much advancement in this area o f 
C-LMWGs. LMHGs, such as the azobenzene derivatives. Shown here is one example of 
azobenzene derivative with a sugar head group. The LM HG’s were found by combinatorial 
synthesis using solid phase glycolipid synthesis developed by Hamachi and Shinkai. 
Several alkyl and cycloalkyl ester derivatives show very good gelators at very low 






% H  n = 6,9,10,11.12,13,14
35
X >c r^o '
36
Figure 18. The sugar based LM W G’s.
Colema and his co-workers showed that p-cyclodextrin has ability to form gel in pyridine 
itself or in combination with toluene, chloroform, or tetrahydrofuran.44 Exposing this 
system to water disrupts the hydrogen bonding and causes the molecules to crystallize, 
forming a ternary crystal complex o f  P-cyclodextrin, pyridine, and water. The 














Figure 19. The sugar based p-cyclodextrin LM W G’s.
W ang’s group has studied a variety o f  sugar based compounds for the LM W G’s. 23-24 
Shinkai group mainly worked on the 4,6 position protected sugars for their studies,33 
W ang’s group have focused on the functionalization o f  the anomeric, 2 and 3 position o f 
the sugar moiety. The syntheses o f  these amide, urea, carbamate, diacetylene containing 
compounds have been studied. Stimuli responsive polydiacetylenes were also prepared 
by the cross-linking o f the diacetylene-containing glycolipids shown in Figure 20.46
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Figure 20. The sugar based amide, urea, carbamate, diaeetylene based LM W G’s.
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1.1.5. PEPTOIDS
Peptoids, oligomers o f N-substituted glycines, are described as a m otif for the generation 
o f  chemically diverse libraries o f  novel molecules. The main difference between peptoids 
and peptides is the side chain is connected to the nitrogen o f the peptide backbone, 
instead o f  the a-carbon as in peptides. Notably, peptoids lack the amide hydrogen which 
is responsible for many o f the secondary structural elements in peptides and proteins as 
shown in Figure 21.49'51
Peptide:
o  r 2
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Figure 21. Schematic comparison between peptides and peptoids.
1.1.6. APPLICATIONS OF LMWGs
The special interests in LM W G’s are associated with their inherent electronic properties 
such as fluorescence, charge carrier mobilities, electronic conductivities, nanomaterials, 
biological areas etc. Therefore, in recent years, considerable effort has been put in by the
23
scientific community to the design o f LM W G’s for specific application in the field o f 
advanced materials. Supramolecular organization o f chromophores attained through 
gelation approach induces strong electronic communication between the individual 
gelators, resulting in remarkable modulation o f  the electronic properties. A few good 
applications are discussed below.
Material Applications:
The recent development LM W G’s in the field o f conducting nanowires o f functional n- 
conjugated molecules are attracted the considerable attention because o f  their potential 
candidates in organic electronic devices. Self-assembled 1-D structures o f organogelators 
show enhanced conductivity due to electron hopping through intermolecular interactions. 
In many cases, conducting properties o f organogels were investigated in the film states 
obtained from the xerogels on different substrates.
Stupp and his coworkers synthesized the thiophene based organogealtors for the 
conducting nanowires.31k The iodine doped xeogel film o f the oligo (thiophene) DRC 







Figure 22. Conducting nanowired organo n gelator.
Shinkai and his coworkers synthesized and characterized a series o f  redox responsive 
chiral gels based on quater-, quinque-, and sexi-thiophenes bearing cholesteryl groups at 
the a-position, as shown in Figure 23. In addition to the unique thermochromic 
properties, sol-gel phase transition has been achieved by the addition o f  oxidizing and 
reducing reagents such as FeClj and L-ascorbic acid respectively.47
53
Figure 23. A thiophene based organo n gelator.
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Biological applications:
Bing X u’s group have developed an enzyme based trigger and control the self-assembly 
o f small molecules for hydrogelation, which takes place in vitro or in vivo, extra- or intra 
cellularly.48 Using phosphatase, they illustrated the design and application o f  enzyme- 
catalyzed or regulated formation o f supramolecular hydrogels that offer a new strategy 
for detecting the activity o f  enzymes, screening for enzyme inhibitors, typing bacteria, 
drug delivery systems, and controlling the fate o f cells. Since the expression and 
distribution o f enzymes differ by the types and states o f cells, tissues, and organs, using 
an enzymatic reaction to convert precursors into hydrogelators that self-assemble into 
nanofibers as the matrices o f the hydrogel, one can control the delivery, function, and 
response o f a hydrogel according to a specific biological system.
Compound 54 have tyrosine phosphate to the C-terminal end o f the amino acid derivative 
afforded the precursor, which served as a substrate for the phosphatases in the 
hydrogelation. The use o f enzymes to trigger and control the self-assembly o f  small 
molecules for hydrogelation, which takes place in vitro or in vivo, extra- or intracellularly 






Scheme 1. The process for using phosphatase to control the balance between hydrophilic 
and hydrophobic interactions that leads to the formation o f a hydrogel.
Bing X u’s group also studied the formation o f a hydrogel within a cell, an endogenous 
enzyme should convert a soluble precursor, which does not necessarily self-assemble and 
gel extracellularly, into a hydrogelator that self-assembles into nanofibers. The design 
and synthesis o f  56 as an esterase substrate was shown in Scheme 2. Mammalian cells 
take in 57 by diffusion, their endogenous esterases convert 56 to 57, and the molecules o f 





Scheme 2. An esterase to convert precursor molecule.
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1.2. INTRODUCTION TO SULFINAMIDE
The development o f  new asymmetric catalysts for organic transformations is an 
important research goal in modem synthetic organic chemistry. The synthesis o f 
enantiomerically pure chiral amines and their derivatives is also very important. There 
are so many methods developed for the preparation o f chiral amine derivatives from 
chiral N-tert-butyl sulfmamide. The extensive study is focused on the N-tert-butyl 
sulfinamide because o f its important in pharmaceutical, biological, and synthetic 
chemistry. The use o f chiral ligands as a source o f  asymmetric induction in metal- 
catalyzed reactions has been a traditional focus o f this field.52
Some o f the available drug molecules were synthesized using the N-tert-butyl 
sulfonamide shown in Fig 24.l64a
S esq u iterpenes: the antagonist: the
lead co m p o u n d  o f  anti-tum or antidepressant
The frist se lec tiv ity  5-H T 4 receptor  
antagonist: the lead com pound o f
G em citabine: an titum or and antiviral 
It is used to treatm ent o f  pancreatic  
cancer, non-sm all cell lung cancer
58 59 60
Figure 24. Drug molecules with chiral amine.
Ellman and his coworkers first synthesized and isolated the enantiomerically pure tert- 
butanesulfinam ide.l64b Since then, several different approaches to the synthesis o f  this
28
compound have been reported, including enantioselective oxidation, resolution o f 
racemic material, diastereoselective synthesis utilizing stoichiometric chiral auxiliaries
164bshown in Scheme 3.
Scheme 3. First synthesis o f tert-butanesulfinamide
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Senanayake and co-workers developed a chiral auxiliary-based method for the synthesis 
o f diverse chiral sulfoxides and sulfmamides, including tert-butanesulfinamide from 
amino indanol, norphedrine, and quinine (Figure 25).53a'c
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N-Acyl amino alcoholAmino Indanol QuinineNorephedrine
Figure 25. Different chiral auxiliaries for synthesis o f tert-butanesulfinamide.
1.2.1. APPLICATIONS OF SULFINAMIDE  
Synthesis o f SC-53116
Ellman and his coworkers developed a self-condensation methodology for the aldimines 
in a diastereoselective intermolecular self-condensation reaction was used for the 
synthesis o f  the highly potent and selective serotonin 5-HT4 agonist SC-53116 (59) 
(Scheme 4). For the self-condensation o f  68, lithium hexamethyldisilazide (LHMDS) 
was identified as the optimal base, and 69 was generated in 55% yield as a 91:5:4:0 
mixture o f  diastereomers. After condensation, microwave irradiation o f iV-sulfinyl imine 
69 produced nitrile 70 which was separated from the minor diastereomers by column 
chromatography and was subsequently reduced to the primary amine 71. Amide-bond 
formation yielded intermediate 72 in 80% yield. Removal o f the sulfinyl and acetal 
protecting groups and cyclization to form the pyrrolizidine core was achieved under
30
acidic reducing conditions. This highly efficient synthesis o f  59 was completed in five 
steps and 29% overall yield from the iV-ferr-butanesulfinyl imine 68.54
Scheme 4. Synthesis o f  5-HT4 receptor antagonist
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antidcpressant gg
Synthesis o f a-Branched amines:
For the synthesis o f  a-branched amines from imines can be easily accomplished by using 
chiral t-butylsulfinamide. The additions o f  organometalic reagents or different 
nucleophiles have proven to get good diastereo selectivity o f chiral amine using this 
auxiliraies. Ellman and his coworker reported the first Grignard reagent to attack the N- 
tert-butanesulfinyl aldimines shown in scheme 5 .164a
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Scheme 5. Addition o f aliphatic Grignard reagent to aldimines
R2MgBr
(3M in EtzO) HCI NH3.HCI
r A h  °  CH 2 CI2  r 1 ^ r 2  MeOH R i r 2
73
-48 °C, 4-6h 78-100%
74 R 2  = Me, Et, iPr, vinyl
R 1= Ph , PhC H 2  
75
Senanayake and coworkers used the aryl Grignards for the addition o f aryl aldimines in
the synthesis o f (S)-cetirizine dihydrochloride as shown in scheme 6. 55






















80 (S)-Cetirizine Hydrochloride 
81
Synthesis of a-Amino acid derivatives:
Davis and co-workers published the first report on alpha amino acids synthesis by 
addition o f Grignard reagent to N-tert-butanesufinyl imino esters. The addition o f
32
BnMgCl to the N-tert-butanesufmyl aldimine (82) in presence o f  2 equiv.of BF3.0Et2 
will provide amino acid derivatives (83) with good diastero selectivity as shown in 
Scheme 7.56
Scheme 7. Synthesis o f  a-Amino acid derivatives
BF3*OEt2 
] nO in Et20
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Yus and coworkers developed the asymmetric synthesis for the synthesis o f  a,a- 
disubstituted amino acids from N-tert-butanesulfmyl imino esters. Reaction o f  triorgano 
zincate reagent with the N-tert-butanesulfmyl imino esters will give the highly substituted 
amino acid derivatives shown in Scheme 8.57'58
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Scheme 8. Synthesis o f a ,a -  disubstituted amino acid derivatives
EtMgBr/ Me2Zn V "
e 3
N 'S*0  THF h N 'S ^0
0R 78 °c °vS r0R
0  OEt O
88 89
R= Et, 96%, 96:4 dr
R= iPr. 82%, 79:21 dr
Synthesis o f p-Amino acid derivatives:
Ellman and coworkers developed the asymmetric synthesis for the synthesis o f (1-amino 
acids from N-tert-butanesufmyl imino esters.59'60 For these compounds high 
diastereoselectivty can be obtained from up on addition o f TiCl(OiPr)3 shown in Scheme 
9.
Scheme 9. Synthesis o f P-Amino acid derivatives
O r l, rs O
3 S ™ A iPr)3
r<- • H - * R ■-' OR4 T H F , -7 8  °C  ”  R ’
90 91 9 2
Synthesis o f 1,2-Diamino derivatives:
Ando and co-workers reported the stereoselective addition o f  aryl Grignard reagent to R- 
amino imine 95 to provide chiral protected diamine 97 in 77% yield. Compound 97, 
which was ultimately converted to an imidazolines for SAR studies on the inhibition o f 
neuropeptide Y5 receptor shown in Scheme 10.61
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Total Synthesis o f (-)-Melotenine A :
Andrade and coworkers synthesized the (-)-Melotenine A is a monoterpene indole 
alkaloid belonging to the Aspidosperma class o f natural products. The synthesis o f  (-)- 
melotenine A is outlined in Scheme 11, began by condensing commercial N-tosyl indole- 
3-carboxaldehyde 98 and (R)-N-tert-butanesulfinamide with Ti-(OEt)4 and In0. Addition 
o f  allyl bromide resulted in formation o f an allyl indium species which stereoselectively 
added to the preformed N-sulfinylimine to afford homoallylic sulfinamide 99 in 87% 
yield (d.r.=10:l). From this they transformed in to (-)-Melotenine A.62
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Scheme 11. Total synthesis o f (-)-Melotenine A staring from aldimine
C H O
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PEPTOID BASED SMALL MOLECULE GELATORS FROM MULTI
COMPONENT REACTION
2.1. INTRODUCTION
Small molecular gelators are interesting compounds that can self-assemble in organic 
solvents or water and form typically fibrous supramolecular architecture. These low 
molecular weight gelators produce thermoreversible physical gels which have potential 
applications in biomedical research and materials science.1,2b’63'66 The driving forces for 
supramolecular gelation are non-covalent forces such as hydrogen bonding, hydrophobic 
interactions, n-n stacking, and Van der W aal’s forces, etc. The gelation by LMWGs 
occurs through non-covalent interactions, the process is typically reversible which can 
result in advanced soft materials. Small molecule self-assembly has shown great promise 
as a “bottom up” approach for preparing novel functional materials.63'73 The three- 
dimensional networks formed by LMWGs are useful new materials with applications in 
various fields, including enzyme immobilization and biocatalysis, tissue engineering and 
drug delivery systems, and advanced nanomaterials.69'73 These interesting applications, a 
great deal o f  effort has been devoted to finding new types o f  low molecular weight
I ̂  9*7
gelators. ' The structures o f low molecular weight gelators (LMWGs) encompass a 
wide range o f different functionalities. Several classes o f  organic compounds have been 
found to be useful building blocks for the design and synthesis o f  LMWGs, these include 
amino acids, sugars, cholesterols, amides, and ureas.88
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These gelators obtained from bio based starting materials such as amino acids and 
carbohydrates will in general produce biocompatible materials or degradation products. 
Peptide based hydrogelators have been extensively studied and have shown great 
promises in tissue engineering and drug delivery.89' 104 However, peptides are endogenous 
compounds that are essential for many biological processes, they suffer from intrinsic 
problems such as rapid clearance or degradation by proteases. Therefore, peptidomimetic 
organo/hydrogelators that contain certain structural feature o f  the peptides but can 
withstand the proteolysis will have applications in obtaining stimuli responsive advanced 
materials.
Since peptide based molecular gelators have shown importance in biomedical and 
materials research, to prepare peptoids which are more resistant to degradation will be a 
useful endeavor. In this study, we have designed and synthesized a small library o f 
tripeptoids using simple building blocks by Ugi reaction. The multiple component 
reactions are useful for generating a diverse array o f  compounds and for analyzing their 
properties. Ugi reaction has not been used much in preparing low molecular weight 
gelators, though there have been studies o f using the reaction in modification o f polymer 
gelator and recently octa-peptoids-peptide hybrids have also been shown to function as 
hydrogelators.105 Peptoids have been shown to be able to self-assemble and form fibrous 
netw orks.105' 106
As shown in Scheme 12, the Ugi reaction is a very efficient reaction involving four 
components in a one pot reaction, in which an acid, an isocyanide, an aldehyde or ketone
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108and an amine condense into a tripeptoid 1. The reactions are carried out under mild
conditions and usually give high yields. The tripeptoids obtained are analogous to 
tripeptides. This is an ideal reaction for exploring structure diversity and the 
discovery o f novel scaffolds for drugs or new materials.
Scheme 12. Ugi one-pot four component reaction
2.2. RESULTS AND DISCUSSIONS
For this study, we selected the readily available amines and carboxylic acids (2-18) as the 
building blocks for the Ugi reaction, as shown in Figure 26. In order to simplify product 
purification, formaldehyde was chosen as the aldehyde component, which can produce a 
glycine unit in the product. Among the various building blocks, the isocyanide 
component is the least commercially available starting materials. We selected cyclohexyl 
isocyanide 21, which is based on our previous studies that compounds containing 
cyclohexyl group generally are effective gelators.85'87 Ethyl 2-isocyanoacetate 22 was 
selected due the resulting glycine ester products. Toluenesulfonylmethyl isocyanide was 
selected due the presence sulfoxide group, it’s very new type o f functionality for gelator 
molecule. Protected glucosamine 5 and 6 were chosen as the amino building block, these 
molecules can introduce a sugar function into the peptoids. Also in our previous studies, 





range o f  substituents can be tolerated.84'87 From these building blocks we synthesized a 
small library o f peptoids as shown in Figure 27. The gelation properties o f  these 
compounds were then tested in several solvents and the results are shown in Table 1.




NHOM e (CH 2 0 )n
Figure 26. Structure o f the starting materials chosen for the MCR reaction.
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Only two aliphatic acid derivatives 25 and 26 are synthesized here. The rest o f 
compounds contain two aromatic groups in their structures, these will introduce the a n-n 
interaction, which is an important factor in hydrogleators designs. From the table 1 we 
can see that a majority o f  these compounds were able to form gels in at least one o f the 
tested solvents, several compounds turned out to be efficient gelators for ethanol aqueous 
solutions and DMSO aqueous solutions. The best performing compound is 32, which 
forms gels at 0.2 wt% in DMSO/water (1:2) mixture. A general trend for these 
compounds is that branching or substitutions on the aryl group generally are necessary 
for gelation. The ethyl glycine series are in general more efficient gelators than those 
cyclohexyl series. Among the different amines used, the p-methoxylbenzylamine 
performed the best, and the protected glucosamine also give products that are effective 
gelators, unsubstituted benzyl group didn’t perform well. Among the different acids 
tested, aryl acids are in general more efficient than aliphatic acids, and substituted aryl 
groups performed much better than the unsubstituted analogues.




































Table 1. Gelation test results for the library compounds









25 I P S S P S P
26 P S P P G 20.0 G 20.0 G 20.0
27 I I P P P P P
28 I P s G 20.0 P G10.0 G 5.0
29 I P p G 20.0 P G 20.0 G 10.0
30 S P s P P G 20.0 P
31 P P p G 10.0 P G 5.0 G 6 .6
32 P P p G 10.0 P G 5.0 G 6 .6
33 S s p P P S P
34 I s s P P P G 20
35 P I G
2 0 .0
P G P P
36 P I G
2 0 .0
G 20.0 G 20.0 G 20.0 P
37 I p I G 20.0 G 10.0 G 10.0 G 6 .6
44
Table 1 continued




( 1 :2 )
EtOH:H20
( 1:2 )
38 S S P G 20.0 G 20.0 P
39 P UG 20.0 S UG 20.0 UG 20.0 P
40 1 UG 20.0 UG P G 20.0 P
41 I I S P P P
42 I P G 10.0 G 10.0 G 10.0 S
43 I P S G 20.0 UG 20.0 G 20.0
44 I P S P P P
45 I G 10.0 G 10.0 G 20.0 G 10.0 G 20.0
46 I I P G 20.0 G 20.0 G 10.0
47 I P S UG 20.0 P P
48
I UG17.0 S ND P G 15.0
49a
P UG17.0 s ND UG18.0 I
49b
ND G 21.0 ND ND I P
50 P P S P P P
G, gel at room temperature, the numbers are the corresponding minimum gelation 
concentrations (M GCs) in mg/mL; I, insoluble; ND, not determined; C, crystallize or 
precipitate; S, soluble at ~20 mg/mL.
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Figure 28. Optical micrographs o f  the gels formed by compounds 29 (a-b) solvent 
D M S0:H 20  (1:2) in 10 mg/mL.
Figure 29. Optical micrographs o f the gels formed by compounds 37 (c-d) in solvent 
DMSO: H 20  (1 :2) at 6 .6  mg/mL.
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Figure 30. Optical micrographs o f  the gels formed by compound 32 (c-d) solvent 
D M S0:H 20  (1:2) at 2.0 mg/mL.
e  h
Figure 31. Optical micrographs o f the gels formed by compound 32 (e-f) in solvent 
EtOH:LLO (1:2) at 2.8 mg/mL.
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Figure 31 shows the optical micrographs o f several gels. The compound 29 formed gel in 
DMSO aqueous mixture at 10 mg/mL, which is not a very efficient gelator, the 
morphology o f  the gel appeared as rod or sheet like feature (Figure 28 a-b). Compound 
37 form gel in DMSO/H2O (1:2) at 0.66 wt% which is a more efficient gelator, and the 
gels formed thinner fibrous assembly (Figure 29 c-d). The compound 32 is the most 
efficient gelator identified in this study, interestingly the morphology o f the self­
assembled structures in DMSO/H2O and EtOH/ELO both appeared as very long and 
uniform fibrous assemblies. The DMSO/H2O gel in the edge part appeared to form a 
cluster o f fibers bundled together during the drying process while in the mild o f  the 
sample showed more separated fibers (Figure 30 e-f). The EtOH/FLO gel has shown 
more uniform fibrous structure with average diameter o f 0.5 pm and over 300pm in 
length (Figure 31 g-h). The morphology study indicated that there is certain correlation 
between the gelation efficiency and the fibrous assemblies.
Table 2. Gel Melting Temperatures
Compound MGC in DMSO:H20  (1:2), (mg/mL) T1 (°C)(a| T2 (°C),b) T3 (°C)<C)
26 2 0 .0 95 100 110
28 5.0 78 80 90
29 1 0 .0 91 95 110
31 6 .6 91 110 120
32 2 .0 70 75 81
34 2 0 .0 50 52 58
37 6 .6 110 118 128
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a) Temperature at which gel begins to melt.
<b) Temperature at which gel is approximately half melted.
(c) Temperature at which gel is fully melted.
The melting points were measured at their minimum gelation contractions in DMSChFhO 
(1:2, volume ratio) as shown in table 2. T1 is the temperature o f  the initial melting, T2 is 
the temperature when the gel is estimated half melted, and T3 is the temperature when the 
gel turned to clear. The melting temperature o f the gel is estimated based on the 
disappearance o f  the opaqueness o f  the initial gels. In general, a compound was dissolved 
in a small vial at their minimum gelation concentrations and then transferred into a small 
tube (such as NM R tube) using a pipette while it was still warm. The tube was then 
sonicated and cooled till a stable gel is reformed. The tube was immersed in oil bath and 
the temperature o f  the solid phase to liquid phase transition was monitored using a 
thermometer.
These initial structure gelation properties from the focused small library (compounds 25- 
37) helped us to design more efficient gelators and also better understand the tripeptoid 
properties in organic/aqueous mixtures. After screening these compounds, the series was 
extended to different functionalities (compounds 38-50), mainly focused on the variation 
o f  acid and amines shown in Figure 27. This new peptoid series forms gels, if  the 
compounds contain the head group amine like 42, 43 and 45, if  there is no head group in 
the peptoid system, compounds are not behaving well. Also if the compound contains 
electron donor and acceptor functionality such as methoxy and bromo (example
compound 35), those compounds shows good gelation behaviour. Still we are in a search
for the new class o f  system which will behave well in both organic/aqueous mixtures by 
modifying amine, aldehyde, isocyanides and acid.
49
For all these compounds the purity was tested by 'H NMR. I3C NMR spectra and LC-
MS. For few compounds !HNMR. ,3C NMR spectra were shown in Figure 32 and 33 
and their chemical shift values were discussed in experimental section.
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These gelators represent a new class o f  organo/hydrogelators and can have potential 
applications in medicinal chemistry and in the entrapment and delivery o f  drugs. These 
preliminary structure gelation properties from a focused small library can help us to 
design more efficient gelators and also to better understand the tripeptoids properties in 
aqueous solutions. Further structure optimization and understanding o f  the properties and 
applications o f these compounds are ongoing.
2.3. CONCLUSIONS
In summary, we have designed and synthesized a series o f  low molecular weight 
tripeptoids by a one-pot Ugi reaction and obtained several effective organo/hydro 
gelators. These compounds are brand new class o f  organogelators that have not been 
reported before. Using MCRs to discover low molecular weight gelators is a novel 
method that will produce interesting structures with a variety o f  potential applications. 
Also the resulting gels should be more resistant to peptidase and this feature may be 
necessary for certain applications.
2.4. EXPERIM ENTAL SECTION  
General Methods:
Reagents and solvents were obtained from commercial suppliers (Sigma-Aldrich, Acros, 
Fisher etc.) and used directly without any purifications. All reactions, unless otherwise 
noted were carried out in oven dried glassware under nitrogen atmosphere. Combiflash 
chromatography was carried out using silicycle 230-400 mesh silcagel. Thin-layer 
chromatography (TLC) analysis was performed with Merck Kieselgel 60 F 254 plates,
52
and visualized using UV light and phosphomolybdic (PMA) staining. 'H  NM R and
t -I
proton-decoupled C NMR spectra were obtianed with Bruker 400 M Hz spectrometer in 
CDCI3 with TMS as an internal standard. Proton and carbon spectra chemical shifts were 
reported using TMS and CDCI3 as internal standard at 0 ppm and at 77.23 ppm, 
respectively.
General procedure using compound 27 as an example:
Benzyl amine (50 mg, 0.46 mmol) was added to a solution o f  paraformaldehyde (0.013 g, 
0.46 mmol) in methanol ( 6  mL), the solution was stirred at room temperature for lh. 
Then benzoic acid (0.055 g, 0.46 mmol) was added followed by cyclohexyl isocyanide 
(0.051 g, 0.46 mmol).The reaction was monitored using TLC which indicated completion 
after 24h. The reaction mixtrure was diluted with DCM (15 mL), washed with water (10 
mL), the organic layer was dried over sodium sulfate and concentrated under reduced 
pressure. The crude product was purified using 60% EtOAc.Hexane. The desired product 
was obtained as a white solid (0.145 g) in 8 8 % o f yield. All other compounds were 
synthesized by a similar procedure. The following are their characterization data.
N-benzyl-N-(2-(cyclohexylamino)-2-oxoethyl)acetamide (25):
The pure compound was obtained as a white solid with 0.112 g (83 %), m.p. 122.0-124.0 
°C. 'H  NM R (400 MHz, CDCI3): (mixture o f rotamers) 6  0.82 (m, 2H), 1.07 (m, 4H), 
1.26 (m, 4H),1.59 (m, 7H), 1.75 (m, 3H), 2.05 (s, 1H), 2.13 (s, 3H), 3.62 (m, 1H), 3.82 (s, 
1H), 3.85 (s, 2H), 4.54 (s, 1H), 4.58 (s, 2H), 5.47 (d, 7.2 Hz, 1H), 6.15 (d, J =  7.2 Hz,
1H), 7.08 (m, 2H), 7.20-7.31 (m, 6 H). 13C (100 MHz, CDC13): (mixture o f  rotamers) 5
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21.4, 21.7, 24.7, 24.8, 25.3, 25.5, 32.7, 32.8, 48.1, 48.2, 50.5, 50.7, 52.5, 53.3, 126.6,
127.9, 128.0, 128.6, 129.0, 129.1,135.8, 137.0, 166.8, 167.9, 171.5, 171.9. HRMS (ESI+) 
calcd for C ,7H24N 2O2 [M+Na]+ 311.1729; found 311.1727.
N-benzyl-N-(2-(cycIohexylamino)-2-oxoethyI)pent-4-ynamide (26):
The pure compound was obtained as a white solid with 0.109 g (71 %), m.p. 138.0-140.0 
°C. ]H NMR (400 MHz, CDCI3): (mixture o f rotamers) 6  0.93 (qd, J =  11.8 Hz, 1H), 1.14 
(m, 3H), 1.34 (m, 3H), 1.68 (m, 6 H), 1.87 (m, 2H), 1.99 (m, 1H), 2.58 (m, 2H), 2.69 (m, 
2H), 3.71 (m, 1H), 3.92 (s, 1H), 3.97 (s, 2H), 4.65 (s, 1H), 4.70 (s, 2H), 5.58 (d, J =  8.0 
Hz, 1H), 6.24 (d, / =  8.0 Hz, 1H ), 7.19 (d, 7.3 Hz, 2H), 7.34 (m, 5H). ,3C (100 MHz,
CDCh): (mixture o f rotamers) 8  14.5, 14.7, 24.7, 24.8, 25.3, 25.5, 31.9, 32.3, 32.8, 32.9,
48.1, 48.4, 50.7, 50.9, 51.5, 52.4, 69.0, 69.1, 126.5, 127.9, 128.0, 128.6, 129.0, 135.6,
136.8, 166.7, 167.7, 171.9, 172.4. HRMS (ESI+) calcd for C2oH26N20 2 [M+Na]+, 
349.1886; found 349.1884.
N-benzyl-N-(2-(cyclohexylamino)-2-oxoethyl)benzamide (27):
The pure compound was obtained as a white solid with 0.145 g ( 8 8  %), m.p. 104.0-106.0 
°C. 'H  NM R (400 MHz, CDCI3): (mixture o f  rotamers) 8  1.10 (m, 4H),1.28 (m, 3H), 1.60 
(m, 4H),1.78 (m, 3H), 3.66 (m, 2H), 3.96 (s, 2H), 4.57 (s, 2H), 4.72 (s, 1H), 5.59 (br, 
1H), 6.29 (br, 1H), 7.1 l(m , 2H), 7.22-7.41 (m, 15H). 13C (100 MHz, CDC13): (mixture o f 
rotamers) 8  24.7, 25.5, 32.9, 48.1, 49.4, 54.0, 126.8, 127.1, 127.9, 128.6, 128.9, 130.1,




The pure compound was obtained as a white solid with 0.165 g (82 %), m.p. 168.0-170.0 
°C. 'H  NMR (400 MHz, CDCI3): (mixture o f rotamers) 6  1.06 (m, 5H), 1.26 (m, 4H),
1.58 (m, 6 H), 1.77 (m, 4H), 3.65 (m, 2H), 3.93 (s, 2H), 4.54(s, 2H), 4.66 (s, 1H), 5.78(br. 
s, 1H ), 6.22 (br. s, 1H), 7.18-7.33 (m, 9H), 7.43 (d, J = 7.5 Hz, 2H). 13C (100 MHz, 
CDCI3): (mixture o f rotamers) 5 24.7, 25.4, 32.9, 48.2, 48.4,49.2, 49.7, 51.7, 54.0, 124.5,
127.0, 127.9, 128.6, 128.9, 131.8, 134.1, 135.8, 167.3, 171.8. HRMS (ESI+) calcd for 
C22H25N202Br [M+Na]+, 451.0991; found 451.0997.
N-benzyl-N-(2-(cyclohexylamino)-2-oxoethyl)-4-nitrobenzamide (29):
The pure compound was obtained as a white solid with 0.162 g (87 %), m.p. 190.0-192.0 
°C. 'H  NMR (400 MHz, CDCI3): (mixture o f rotamers) 8  1.10 (m, 10H), 1.67 (m, 10H),
3.59 (s, 1H), 3.68 (m, 2H), 3.98 (s, 2H), 4.52 (s, 2H), 4.73 (s, 1H), 5.22 (s, 1H), 5.89 (d, J  
= 4.8 Hz, 1H), 7.08 (d, J =  6.5 Hz, 2H), 7.28 (m, 7H), 7.58 (d, J = 8.0 Hz, 2H), 7.63 (d, J 
= 7.5 Hz, 2H), 8.17 (m, 2H). 13C (100 MHz, CDCI3): (mixture o f rotamers) 5 24.7, 25.3,
25.4, 25.5, 30.5, 33.0, 48.4, 48.9, 53.9, 123.9, 126.9, 127.9, 128.0, 128.1, 128.2, 128.6,
128.7, 129.0, 129.1, 135.3, 141.4, 148.6, 166.8, 170.6. HRMS (ESI+) calcd for 
C22H25N3O4 [M + N af, 418.1737; found 418.1741.
(R)-4-bromo-N-(2-(cyclohexylamino)-2-oxoethyl)-N-(l-phenyIethyl)benzamide (30):
The pure compound was obtained as a white solid with 0.131 g (71 %), m.p. 140.0-142.0 
°C. 'H  NMR (400 MHz, CDC13): (mixture o f rotamers) 8  1.09 (m, 3H), 1.27 (m, 3H ), 
1.48 (m, 2H), 1.55 (s, 2H), 1.56 (s, 3H), 1.75 (m, 2H), 3.37 (m, 2H), 3.63 (s, 3H), 4.15 (d,
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J =  14.6 1H), 4.50 (s, 1H), 6.40 (br. s, 1H), 7.13 (br, 1H), 7.23 (m, 2H), 7.27 (m, 5H), 
7.50 (m, 2H). 13C (100 MHz, CDC13): (mixture o f rotamers) 6  17.9, 24.6, 25.5, 32.7, 32.8,
47.1, 48.0, 57.6, 64.2, 124.2, 126.7, 127.0, 128.0, 128.7, 128.9, 132.0, 134.7, 139.1,
168.3, 171.8. HRMS (ESI+) calcd for C23H27N20 2Br [M+Na]+, 465.1148; found 
465.1156.
N-(4-methoxybenzyI)-4-bromo-N-(2-(cyclohexylamino)-2-oxoethyl)benzamide (31):
The pure compound was obtained as a white solid with 0.132 g (79 %), m.p. 174.0-176.0 
°C. 'H  NM R (400 MHz, CDC13): (mixture o f  rotamers) 5 1.09 (m, 4H), 1.29 (q, J =  12.0 
Hz, 3H ), 1.58 (m, 5H), 1.79 (m, 3H), 3.67 (m, 2H), 3.73 (s, 3H), 3.93 (s, 2H), 4.48 (s, 
2H), 4.64 (s, 1H), 6.11 (d, 1H), 6.80 (d, J=  8.3 Hz, 2H), 7.00 (d, J=  5.3 Hz, 2H), 7.29 (d, 
J =  8.3 Hz, 2H), 7.46 (d, J = 7 .8  Hz, 2H). 13C (100 MHz, CDCI3): (mixture o f rotamers) 6  
24.71,24.74, 25.4,48.2, 49.2, 53.5,55.3, 114.3, 124.5, 128.4, 128.6, 131.8, 159.4, 167.4,
171.7. HRMS (ESI+) calcd for C 23H27N 20 3 Br [M+Na]+, 481.1097; found 481.1103.
Ethyl 2-(2-(N-(4-methoxybenzyl)-4-bromobenzamido)acetamido)acetate (32):
The pure compound was obtained as a white solid with 0.112 g ( 6 6  %), m.p. 123.0-125.0 
°C. 'H  NMR (400 MHz, CDCI3): (mixture o f rotamers) ) 6  1.23 (m, 3H ), 3.82 (s, 3H), 
4.02 (d, J=  5.3 Hz, 2H), 4.12 (br, s, 2H), 4.24 (q, J=  7.0 Hz, 2H), 4.57 (br, 2H), 6.89 (m, 
2H), 7.13 (d, J  = 5.0 Hz, 2H), 7.43 (m, 2H), 7.56 (d, J  = 8.0 Hz, 2H). 13C (100 MHz, 
CDCI3): (mixture o f rotamers) 6  14.1, 41.2, 48.4, 53.4, 55.3, 61.6, 114.3, 124.5, 128.4,
128.7, 131.8, 134.0, 134.1, 158.2, 159.4, 168.6, 169.6, 171.9. HRMS (ESI+) calcd for 
C 21H23BrN20 5 [M+Na]+ , 485.0682; found 485.0680.
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Ethyl 2-(2-(N-benzyIbenzamido)acetamido)acetate (33):
The pure compound was obtained as a light yellow oil with 0.134 g (81). !H NMR (400 
MHz, CDCh): (mixture o f rotamers) 5 1.22 (m, 3H ), 3.67 (s, 2H), 3.91 (d, J =  3.5 Hz, 
2H), 4.04 (br, s, 2H), 4.13 (q, J=  7.0 Hz, 2H), 4.57 (br. s, 2H), 4.74 (s, 1H), 6.90 (s, 1H), 
7.12 (s, 2H), 7.21-7.35 (m, 8 H), 7.44 (m, 2H). I3C (100 MHz, CDC13): (mixture o f 
rotamers) 5 14.2, 41.0, 41.2, 48.6, 52.3, 53.9, 61.5, 126.9, 127.1, 127.9, 128.6, 128.9,
130.2, 135.1, 135.8, 168.9, 169.6, 173.0. HRMS (ESI+) calcd for; C 20H22N2O4 [M +N a]\ 
377.1471; found 377.1471.
Ethyl 2-(2-(N-(4-methoxybenzyl)benzarmdo)acetamido)acetate (34).
The pure compound was obtained as a white solid with 0.094 g (67 %), m.p. 94.0-96.0 
°C. 'H  NMR (400 MHz, CDCI3): (mixture o f rotamers) 5 1.22 (m, 3H ), 3.72 (s, 3H), 3.92 
(d, J  = 5.3 Hz, 2H), 4.04 (br, s, 2H), 4.13 (q, J  = 7.0 Hz, 2H), 4.57 (br, 2H),6.79 (d, J  = 
8.5 Hz, 2H), 6.99 (m, 1H), 7.03 (d, J =  5.5 Hz, 2H), 7.34 (m, 3H), 7.44 (m, 2H). 13C (100 
MHz, CDCh): (mixture o f  rotamers) 6  14.1, 41.2, 48.4, 53.4, 55.3, 61.5, 114.2, 126.9, 
127.5, 128.3, 128.6, 130.0, 130.1, 133.1, 135.2, 159.3, 168.9, 169.6, 172.9. HRMS 
(ESI+) calcd for C 21H24N2O 5 [M+Na]+, 407.1577; found 407.1575.
N-(2-(cyclohexyIamino)-2-oxoethyl)-N-(8-hydroxy-6-methoxy-2-phenyl- 
hexahydropyrano[3,2-dl[l,3]dioxin-7-yl)benzam ide (35)
The pure compound was obtained as a white solid with 0.083 g (89 %), m.p. 261.0-263.0 
°C. 'H NMR (400 MHz, CDCI3): 5 1.08 (m, 3H), 1.27 (m, 2H), 1.58 (m, 3H), 1.87 (dd, J  
= 18.6, 14.1Hz, 2H), 3.30 (s, 3H), 3.46 (t, J =  9.2 Hz, 1H), 3.59 (m, 1H), 3.72 (m, 2H),
57
3.90 (dd, J  = 10.0, 3.5 Hz, 1H), 4.12 (m, 2H), 4.17 (d, 7  = 4.8 Hz, 2H), 4.45 (d, J =  3.5 
Hz, 1H), 5.44 (s, 1H), 5.83 (d, 7 = 8 .0  Hz, 1H), 6.49 (d, 7  = 1.5 Hz, 1H), 7.26 (dd, 7 = 5 .0 ,
1.8 Hz, 3H), 7.33 (d, 7  = 8.3 Hz, 2H), 7.42 (m, 2H), 7.50 (d, 7  = 8.3 Hz, 2H). 13C (100 
MHz, CDC13): 5 24.6,25.4, 32.9, 47.6, 49.0, 55.2, 62.7, 63.3, 6 6 .6 , 68.7, 80.9, 100.8,
101.7, 124.1, 126.3, 128.2, 128.8, 129.0, 132.0, 134.0, 137.1, 169.7, 172.5. HRMS 
(ESI+) calcd for C29H36N 2O7 [M+Na]+, 547.2414; found 547.2420.
4-Bromo-N-(2-(cydohexylamino)-2-oxoethyI)-N-(8-hydroxy-6-methoxy-2-phenyl- 
hexahydropyrano[3,2-d][l,3Jdioxin-7-yl)benzamide (36)
The pure compound was obtained as a white solid with 0.098 g (91 %), m.p. 291.0-293.0 
°C. 'H  NM R (400 MHz, CDCh): 5 1.1 (m, 3H), 1.26 (m, 2H), 1.53 (m, 1H), 1.62 (m, 
2H), 1.87 (m, 2H), 3.31 (s, 3H), 3.48 (m, 1H), 3.62 (m, 1H), 3.73 (m, 2H), 3.84 (d d ,7  =
9.9, 3.6 Hz, 1H), 4.15 (m, 4H), 4.44 ( d ,7 =  3.5 Hz, 1H), 5.46 (s, 1H), 5.78 ( d ,7 =  8.0 Hz, 
1H), 6.49 (d, 7 =  1.5 Hz, 1H), 7.27 (dd, 7  = 5.0, 1.8 Hz, 3H), 7.33 (d, 7 =  8.3, 2H), 7.42 
(m, 2H), 7.50 (d, 7  = 8.3 Hz, 2H ). I3C (100 MHz, CDCh): 6  24.7, 25.4, 32.84, 32.89, 
47.6, 48.9, 55.2, 62.6, 63.3, 66.7, 68.7, 80.9, 100.9, 101.7, 126.3, 127.0, 128.2, 128.7,
129.0, 129.7, 135.2, 137.1, 169.9, 173.5. HRMS (ESI+) calcd for C29H35N20 7 Br 
[M + N af, 625.1519; found 625.1530.
Ethyl 2-(2-(4-bromo-N-(8-hydroxy-6-methoxy-2-phenyI-hexahydropyrano |3,2-| 
[ 1,3 |dioxin-7-yl)benzamido)acetamido)acetate (37)
The pure compound was obtained as a white solid with 0.065 g (61 %), m.p. 207.0- 
209.0 °C. 'H  NMR (400 MHz, CDCh): 5 1.26 (m, 3H), 3.31 (s, 3H), 3.44 (m, 1H), 3.61
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(m, 1H), 3.73 (m ,lH ), 3.82 (dd, 7 =  10.0, 3.5 Hz, 1H ), 3.90 (dd, J =  18.3, 3.3 Hz, 1H),
4.08 (m, 2H), 4.15 (m, 4H), 4.32 (m, 2H), 4.47 (d, J =  3.5 Hz, 1H), 5.44 (s, 1H), 6.05 (d, 
J =  2.0 Hz, 1H), 6 .6 6  (m 1H), 7.26 (dd, J  = 4.9, 1.9 Hz, 3H), 7.21 (d, J =  8.3 Hz, 2H), 
7.40 (m, 2H), 7.50 (d, J =  8.3 Hz, 2H). 13C (100 MHz, CDC13): 6  14.1, 41.6, 47.0, 55.2,
61.8, 62.5, 63.3, 6 6 .6 , 68.7, 81.0, 100.7, 100.8, 124.2, 126.3, 128.2, 128.8, 129.1, 132.0,




SYNTHESIS OF A NEW CLASS OF SUGAR TRIAZOLE 
DERIVATIVES AS MOLECULAR GELATOR BY CLICK
REACTION
3.1. INTRODUCTION
Low molecular mass organic/hydro gelators (LMOGs/LMHGs) are a new class o f  soft 
materials capable o f numerous possible applications. Low molecular weight hydrogels 
are a common class o f biomaterials utilized in a wide range o f applications including as 
tissue engineering scaffolds, drug delivery vehicles. As a result, there is a tremendous 
amount o f work focused in finding gelling m aterials.’'2a‘c Small molecules that can self- 
assemble in organic solvents or water and form typically fibrous supramolecular 
architectures that immobilize the solvents to form organo/hydrogels. The main driving 
forces for supramolecular gelation are non-covalent forces such as hydrogen bonding, 
hydrophobic interactions, n-n stacking, and van der Waals forces, etc . 109' 111
Because gelation by LMWGs occurs through non-covalent interactions, the modification 
o f the chemical structures o f gelators is expected to affect the noncovalent interactions 
and consequently the properties o f  the corresponding gels. Intermolecular interactions, 
such as 7i-7i stacking, H bonding, and hydrophobic interactions can be modulated to 
entrap solutes and/or solvent molecules within the supramolecular network o f  a gel. 112
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Low molecular weight gelators have wide variety interesting applications. Because o f 
their interesting applications, a great deal o f  effort has been devoted to studying new
based starting materials such as amino acids and carbohydrates will in general produce 
biocompatible materials or degradation products . 124' 130
From the time when its origin by Sharpless in 2001, the concept o f click chemistry has 
been promptly adopted by many disciplines, perhaps most notably in materials science. 
From last decade triazoles have been shown to be able to self-assemble and form fibrous 
networks and recently a few triazole hybrids have been shown to function as
• 118 1
types o f low molecular weight gelators. ' Organo/hydro gelators obtained from bio-
hydrogelators . 113"117
3.2. RESULTS AND DISCUSSIONS
Scheme 13. Synthesis o f azide from N-acetylglucosamine
AcHN
AcCI, rt, 2 4 h
78%
A cH NA cH N
8 5 %II 1
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Scheme 14. Synthesis o f  sugar triazoles from compound 1
N H A c
CuS04, sodium ascorbate
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8 I G 2.0 s s s S s s s
9 I G 1.7 s s s s s s s
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2 .8




s G 20.0 G
4.0
12 I G 5.0 s p p G 6.7 G 10.0 G 2.2 P
13 I S s s G 2.5 G 2.8 G 10.0 G 2.2 G
2 .2
14 I S s s G 3.3 G 6 .6 G 2.2 G 1.9 G
2 .0
15 I s s s G 2.2 G 6 .6 G 2.0 G 1.7 G
1 0 .0
16 I I p G
1 0 .0
G 5.0 G 5.0 G 2.5 G 3.3 P
17 I s G
2 0 .0
p P P P P I
G, gel at room temperature, the numbers are the corresponding minimum gelation 
concentrations (MGCs) in mg/mL; I, insoluble; C, crystallize or precipitate; S, soluble at 
20 mg/mL.
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As Shown in Scheme 14 the click chemistry is very capable o f  producing triazoles when 
reacting azide and alkyne in presence o f  Cu (I) and sodium ascorbate. Sodium ascorbate 
reduces copper (II) to copper (I) by change to H 2A in solution.117d This is a perfect 
reaction for exploring structure diversity and the discovery o f  novel scaffolds for drugs or 
new materials . ! l3 ' 117
In this study, in order to obtain the structure features o f simple glucosamine derivatives 
for effective gelators, we synthesized and screened a small library o f  compounds using 
the click reaction. From the peracetylated glucosamine azide 1 by coupling with various 
alkynes, a library o f  triazole derivatives are obtained readily. The selection o f  the alkyne 
functional groups is based on their polarity and availability o f starting materials. As 
shown in Scheme 14, we synthesized compounds 4-17, which include the typical 
functional groups such as amine (4), alcohols (5-10) and aryl groups (12-13) and alkyl 
groups (14-16) by coupling with the corrections monoalkyne. Compound 17 was 
synthesized using a dialkyne starting material. These compounds were then tested for 
their gelation properties in several solvents. The results are shown in Table 3.
As shown in Table 3, at 20 mg/mL, all o f  these compounds were insoluble in hexane. 
But four compounds were able to gelate toluene, the short chain alchohol derivatives 8 , 9, 
and the acid, aryl analogy 11, 12. A majority o f  the compounds were soluble in ethanol 
and isopropanol, only two compounds were able to form gels in the alcohols. The dimer 
17 formed a gel in isopropanol and the long alkyl chain derivatives 16 formed a gel in
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ethanol. Though they are no effective gelators for alcohols, we were pleased to find that 
many o f  the compounds were efficient gelators for aqueous mixtures o f  ethanol or 
DMSO, and four compounds are also effective hydrogelators. When the R group contains 
non-polar functional groups typically the products are able to form gels in the aqueous 
mixtures.
Figure 34 shows the optical micrographs o f  the gels formed by compounds 10 and 14. 
These images are taken while the gels still contain solvents. As a general feature, these 
various gelators formed self-assembled fibrous networks. Compound 10 formed an 
opaque gel in water at 2.8 mg/mL, the morphology (Figure 34a-c) shows continuous 
fibrous assemblies. The hydrogel formed by compound 14 also exhibit self-assembled 
fibrous features and fibers or tubules have larger diameters (Figure 34d-f) the compound 
14 formed gel in water showed uniform fibers or tubules, these fibers appeared to have 
similar widths and are less branched.
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Figure 34. Optical micrographs o f the gels formed by compound 10 (a-c) in LLO 2.8 
mg/mL and compound 14 (d-f) in H2O 2.0 mg/mL.
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Figure 34 continued
We have also studied the dynamic rheology sweep. In Figure 35 the dynamic moduli G' 
and G" are shown as a function o f  angular frequency to at their minimum gelation 
concentrations for compounds 10. 13 and 15. From the Figure 35. observed that the 
storage modulus G' is greater than the Loss modulus G '' for all these compounds and 
these compounds have high shear stress. The apparent rise o f G' at high frequencies for 
these compounds is an experimental artifact o f  the 25mm peltier plate geometry on the 
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Figure 35. Viscoelastic properties o f the gels formed by compounds 10 (LLO, 2.8 
mg/mL), 13 (H2O. 2.2 mg/mL) and 15 (DMSCLLLO, 1:1, 2.0 mg/mL) at their minimum 
gelation concentration.
After synthesizing the N-Acetyl glucosamine, we have chosen a simple starting material 
D-glucose for the synthesis o f triazole. A series o f available terminal alkyne containing 
alcohols, acid and free alkyne chin have chosen for this synthesis.
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As shown in Scheme 15, the azide can be synthesized from the two step process from D- 
glucose, we fixed the azide starting material similar to previous system and altered the 
various alkynes (Scheme 16). Among the various building blocks we chose terminal 
acids and alcohols for the contribution o f  hydrogen bonding and the aliphatic chain for 
hydrophobic interactions.
Scheme 16. Synthesis o f  sugar tiazoles from compound 20
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Figure 36. a) A clear gel formed by compound 22 in DMSO/H2O (v l:2 ) at 2.5 mg/mL; 
b) A translucent/opaque gel formed by compound 28 in DMSO/H2O (v l:2 ) at 2.5 
mg/mL; c) A translucent/opaque gel compound 33 in EtOH/LLO (vl :2) at 5.0 mg/mL.
The gels formed by these triazoles are typically translucent to opaque, some photographs 
o f  the typical gels are shown in Figure 36. The best performing compound is 25, which 
forms gels at 0.40 wt% in water and also in the combination o f organic and aqueous 
mixtures. Compound 25 forms nice gels because o f the presence o f  long aliphatic chain 
and also the hydroxy group. Hydroxyl group will provide H-bonding and long aliphatic 
chain provides the hydrophobic interactions between the molecules in case o f compound 
25.
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Figure 37. The optical micrographs o f the wet gel samples from several amides, a-c) a 
gel formed by compound 25 in H20  at 4.0 mg/mL. d) a gel formed by compound 22 in 





From the table 4, we can see that compound 24 forms gel in organic/aqueous mixtures, 
this result the presence o f  cyclohexyl ring in the system. This result is similar our 
previous work.30'34because cyclohexyl ring provides strong hydrophobic interactions. We 
have also synthesized the dimerized compound 27 to study the effect o f dimerization in
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formation o f  gels. This compound is also forms nice gel in EtOH/water mix. the 
photograph o f gel is shown in Figure 36.
The optical micrographs o f the gels formed by compounds 22 and 25 were shown in 
Figure 37. These images are taken while the gels still contain solvents. As a general 
feature, these various gelators formed self-assembled fibrous networks. Compound 25 
formed an opaque gel in water at 2.8 mg/mL. the morphology (Figure 37a-c) shows 
continuous fibrous assemblies. The assemblies are composed o f  many long, curvy, thin 
and uniform fibrous networks. The gels formed by compound 22 also exhibit self­
assembled fibrous features and fibers or tubules have larger diameters Figure 37 (d).
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Figure 38. The viscoelastic measurement o f the gels formed by compounds 21 
(D M S0/H 20 ,l /2 )  at 6 .6  mg/mL). 25 (D M S0/H 20 .1 /2) at 2.5 mg/mL. and urea 27 
(EtOH/H20 , 1/2) at 5.0 mg/mL.
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We then studied the stability and elastic properties o f several gels by rheology, the results 
are shown in Figure 38. For the gels formed by compounds 21, 25 and 27, compound 27 
have the high G'/G" value than the compound 21 and 27. This result indicated all the gels 
are stable and have elastic properties with the strong hydrophobic interaction between the 
molecules.
For all these compounds the purity was tested by 'H  NMR, 13C NMR spectra and LC- 
MS. For few compounds spectra’s were shown in Figure 39, 40, 41, 42 and 43. Their 
chemical shift values were discussed in experimental section.
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Figure 42. 'H  NM R (400 MHz, CDC13) and 13C NMR (100 MHz, CDC13) spectra for
compound 24.
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HPLC purity for compound 21:
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Figure 43. HPLC condition: SB-C18 column. 2.1X50 mm. 1.8pm: 0.1% formic acid in 
70:30: acetonitrile/water; 1.0 mL/min; 222nm; r, = 0.5 min.
3.3. C O N C LU SIO N S
In summary, we have synthesized a series o f N-acetyl glucosamine and D-Glucose based 
triazole derivatives and studied their self-assembling properties. Among the analogues 
studied, we found that the compounds containing long aliphatic spacers are generally 
effective low molecular weight gelators. and six efficient hydrogelators have also been 
obtained. These sugar based hydrogels may find potential applications in biomedicical 
research and as advanced materials.
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3.4. EXPERIM ENTAL PROCEDURES 
General Methods
All reactions were carried out under normal condition, reagents and solvents were 
obtained from commercial suppliers used directly without any purification. All the 
solvents were used for the reaction were purchased from Sigma-Aldrich, VWR, and 
Fisher. All reactions, unless otherwise noted were carried out in oven dried glassware 
under nitrogen atmosphere. Chromatography was carried out using silicycle 230-400 
mesh silcagel. Thin-layer chromatography (TLC) analysis was performed with Merck 
Kieselgel 60 F 254 plates, and visualized using UV light. 'H  NMR and proton-decoupled 
13C NMR spectra were obtained with Varian 400 MHz spectrometers in CDCI3. Proton 
and carbon spectra chemical shifts were reported using TMS and CDCI3 as internal 
standard at 0 ppm and at 77.23 ppm, respectively.
Synthesis and characterization data:
Synthesis of compound (II):
To the N-acetyl glucosamine (500 mg, 2.26mmol) acetyl chloride (0.99 mL, 14.05 mmol) 
was added at room temperature. Reaction was kept at room temperature for 12h. After 
12h, TLC (hexane: ethyl acetate: 1:4) indicates no starting material was left. The reaction 
mixture was diluted with DCM (10 mL) and then poured on to ice water (20 mL), and the 
organic layer was washed with saturated NaHCCh for three times then washed with brine 
solution. The organic layer was dried over sodium sulfate and the crude product was 
purified using column chromatography in (hexane: ethyl acetate: 1:4) to get the desired 
product as a white solid with 0.645 g.
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The pure compound was obtained as a white solid with 0.645 g (78 %), m.p. 124.0-126.0 
°C. 'H  NMR (400 MHz, CDC13): 6.17 (d, 1H, J =  3.7 H z ) , 5.87 (d, 1H, J =  8 .8  Hz), 5.25 
(m, 2H), 2.09 (s, 3H), 2.04 (s, 6 H), 1.97 (s, 3H). 13C (100 MHz, CDCI3): 5 171.5, 170.7,
170.5, 169.3, 93.8, 71.0, 70.2, 67.2, 61.3, 53.5, 23.1, 20.8, 20.7.
Synthesis of compound 1:
Compound II  (500 mg, 1.3 mmol) was dissolved in anhydrous DMF ( 8  mL), followed by 
sodium azide (0.27 g, 4.1 mmol) was added at room temperature. Reaction was moved to 
70 °C for 3h, monitored using TLC and NMR after 3h reaction was completed. DMF was 
removed under reduced pressure and worked up with EtOAc and water. The organic layer 
was dried over magnesium sulfate and the crude product was purified using column 
chromatography EtOAc: Hexane (2:1) to get the desired product as white solid 0.458g. 
The pure compound was obtained as a white solid with 0.458 g (90 %), m.p. 166.0-168.0 
°C. 'H  NM R (400 MHz, CDC13): 5.61 (d, 1H, J =  8.7 Hz) ,5.24 (t, 1H, J =  9.1 Hz), 5.10 
(t, 1H, J =  9.8 Hz), 4.75 (d, 1H, J =  9.5 Hz), 4.27 (dd, 1H, J =  12.4, 4.7 Hz), 4.17 (dd, 
1H, J  = 9.3, 2.1 Hz), 3.91 (m, 1H), 3.78 (m, 1H), 2.10 (s, 3H), 2.04 (m, 6 H), 1.98 (s, 
3H). 13C (100 MHz, CDCI3): 6  170.1, 170.7, 170.5, 169.2, 88.3, 73.8, 72.0, 67.9, 61.8, 
54.0, 23.2, 20.7,20.67, 20.61.
General procedure for the synthesis o f triazoles:
To a 50 mL o f round bottom flask 100 mg o f compound (1) (100 mg, 0.26 mmol) and 10- 
undecynoic acid (62 mg, 0.34 mmol) were dissolved in tBuOH: THF: Water: 1:1:1 ( 6  
mL). To this solution copper (II) sulfate ( 8  mg, 0.052 mmol) and L-ascorbic sodium salt
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(21 mg, 0.104 mmol) were added. Reaction was kept at room temperature for 14h. 
Reaction was monitored using TLC and LC-MS, shows the conversion by this time. The 
solvents were evaporated under reduced pressure. The resulting residue was dissolved in 
chloroform (10 mL), washed with water (2 mL) and the extracted crude product was 
purified using flash chromatography EtOAc: Hexane (95:5) (or) DCM:MeOH (97:3) to 
get the desired product as white solid with 0.114 g with 81%.
Compound 4:
The pure compound (4) was obtained as a white solid with 98 mg (81%), m.p. 235.0-
237.0 °C. ‘H NM R (400 MHz, CDC13): 7.79 (s, 1H), 7.28 (d, 1H, J =  8.5 Hz), 6.14 (d, 
1 H ,J =  10.1 Hz), 5.56 (t, 1H, J =  10.1 Hz), 5.18 (t, 1 H ,J =  10.1 Hz), 4.54 (q, 1 H ,J = 9 .3  
Hz), 4.24 (dd, 1H, J  = 9.3, 4.6 Hz), 4.10 (m, 1H), 4.03 (m, 1H), 3.56 (m, 2H), 2.21 (s, 
6 H), 2.05 (m, 9H), 1.72 (s, 3H). I3C (100 MHz, CDCI3): 8  170.7, 170.5, 169.3, 145.0,
122.1, 85.8, 74.6, 72.2, 68.2, 61.7, 53.9, 53.4, 44.9, 22.7, 20.67, 20.62, 20.5. (ESI+) calcd 
for C 19H29N 5O 8 [M+H]+, 456.4 found 456.2.
Compound 5:
The pure compound (5) was obtained as a white solid with 94 mg (82 %), m.p. 230.0-
232.0 °C. 'H  NMR (400 MHz, CDCI3): 8  7.94 (s, 1H), 6.75(d, 1H, J =  9.3 Hz), 6.10 (d, 
1H, J  = 10.1 Hz), 5.48 (t, 1H, J  = 9.3 Hz), 5.26 (t, 1H, J  = 9.3 Hz),4.78 (br, s, 2H), 4.59 
(q, 1H, J =  9.3 Hz), 4.28 (dd, 1H, J =  9.3, 4.6 Hz), 4.12 (m, 1H), 4.03 (m, 1H ),2.46 (br, s 
, 1H), 2.05 (m, 9H), 1.74 (s, 3H). I3C (100 MHz, CDC13): 8  171.2, 170.6, 169.4, 117.4,
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85.7, 74.6, 72.3, 68.1, 61.7, 55.8, 33.0, 22.5, 20.6. (ESI+) calcd for C 17H24N 4O9 [M+Na]+, 
451.4 found 451.1.
Compound 6:
The pure compound (6 ) was obtained as a white solid with 0.129 g (87 %), m.p. 245.0-
247.0 °C. 'H  NM R (400 MHz, CDCI3): 6  7.80 (s, 1H), 6.16 (d, 1H, J  = 7.8 Hz), 6.03 (d, 
1H, J =  10.1 Hz), 5.47 (t, 1H, J = 9 .3  Hz), 5.25 (t, l H , / =  9.3 Hz), 4.57 (q , 1H, J = 9 .3  
Hz), 4.28 (dd, 1H, J =  9.3 ,4.6 Hz), 4.12 (m, 1H), 4.03 (m, 1H), 2.87 (m, 1H), 2.05 (m, 
9H), 1.90 (m, 4H), 1.71 (m, 6 H), 1.55-1.34 (m, 4H). ,3C (100 MHz, CDC13): 8  171.5,
170.6, 169.4, 118.4, 86.0, 74.7, 72.2, 68.0, 53.1, 29.9, 22.2, 20.4. (ES1+) calcd for 
C 19H28N 4O9 [M + N a]\ 479.4 found 479.2.
Compound 7:
The pure compound (7) was obtained as a white solid with 0.100 g (85%), m.p. 185.0-
187.0 °C. ‘H NM R (400 MHz, CDC13): 8  7.78 (s, 1H), 7.32 (d, 1H, J  = 9.3 Hz), 5.87 (d, 
1H, J =  9.3 Hz), 5.35 (t, 1H, J  = 9.3 Hz), 5.19 (t, 1H, J =  9.3 Hz), 4.49 (q, 1 H ,J =  9.3 
Hz), 4.26 (dd, 1H, J= 1 2 .4 , 4.6 Hz), 4.12 (m, 1H), 4.01 (m, 1H), 3.22 (m, 2H), 2.90 (m, 
2H), 2.39 (m, 2H), 2.04 (m, 9H), 1.69 (m, 3H). I3C (100 MHz, CDC13): 8  171.3, 171.2,
170.7, 169.4, 145.9, 121.3, 86.1,74.8, 72.16, 72.12, 6 8 .6 , 61.7,61.2, 53.5, 49.6, 49.0, 28.9,
22.3, 20.6, 20.5. (ESI+) calcd for Q g H s e N ^ M + N a f ,  465.4 found 465.1.
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Compound 8:
The pure compound (8) was obtained as a white solid with 98 mg (82 %), m.p. 225.0-
227.0 °C. 'H  NM R (400 MHz, CDCI3+DMSO): 8  7.59 (d, 1H, 7  = 9.3 Hz), 7.54 (s, 1H), 
5.83 (d, 1H ,7  = 10.1 Hz), 5.24 (t, 1 H ,7  = 9.3 Hz), 5.00 (t, 1 H ,7 = 9 .3  Hz), 4.43 (q, 1 H ,J  
= 9.3 Hz), 4.09 (dd, 1H, 7 = 9 .3 , 4.6 Hz), 3.94(m, 1H), 3.82 (m, 1H), 3.42 (br, s , 1H), 
2.6.2(m, 2H), 1.87 (m, 9H), 1.71(m, 2H), 1.54(m, 2H). ,3C (100 MHz, CDCI3+DMSO): 
8  165.5, 165.27, 165.22, 164.4, 80.8, 69.6, 67.8, 63.4, 56.9, 56.0, 47.6, 26.9, 17.8,17.1,
15.8, 15.6. (ESI+) calcd for [M + N af, 479.4 found 479.2.
Compound 9:
The pure compound (9) was obtained as a white solid with 0.114 g (8 6 %), m.p. 231.0-
233.0 °C. 'H  NM R (400 MHz, CDC13): 8  7.86 (s, 1H), 7.08(d, 1H, 7 =  9.3 Hz), 6.15 (d, 
1H ,7  = 10.1 Hz), 5.52(t, 1H ,7 = 9 .3  Hz), 5.24(t, 1H ,7 = 9 .3  H z),4.61(q, 1 H ,7 = 9 .3  Hz),
4.30 (dd, 1H, 7  =9.3, 4.6 Hz), 4.13 (m, 1H), 4.07 (m, 1H), 2.73 (t, 1H, 7  = 7.8 Hz), 2.69 
(t, 1H, 7 =  7.8 Hz), 2.05 (m, 9H), 1.75 (s, 3H), 1.64 (m, 2H), 1.29 (m, 6 H), 0.86 (t, 3H, 7  
= 7.0 Hz). 13C (100 MHz, CDCI3): 8  170.8, 170.7, 170.6, 169.3, 155.8, 119.4, 85.7, 74.6,
72.3, 69.2, 68.1, 61.7, 53.3, 37.9, 37.7, 25.3, 22.6, 21.8, 20.67, 20.63, 20.5. (ESI+) calcd 
for C 22H32N 2O2 [M+Na]+, 519.5 found 519.2.
Compound 10:
The pure compound (10) was obtained as a white solid with 0.120g (82 %), m.p. 188.0-
190.0 °C. 'H  NMR (400 MHz, CDCI3): 7.72 (s, 1H), 6.02 (m, 2H), 5.42 (t, 1H, 7 =  9.3 
Hz), 5.23 (t, 1H, 7  = 9.3 Hz), 4.60 (m, 1 H ),4 .2 9  (dd, 1H, 7 =  9.3, 4.6 Hz), 4.14 (m, 1H),
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3.97 (m, 1H), 3.63 (m, 2H), 2.70 (m, 2H), 2.07 (m, 9H), 1.79-1.60 (m, 8 H), 1.56 (m, 2H),
1.31 (m, 10H).13C (100 MHz, CDC13): 8  170.68, 170.6, 169.3, 121.0, 85.8, 74.7, 72.5,
68.2, 62.7, 61.7, 53.1, 32.7, 29.3, 29.2, 29.1, 29.0, 20.68, 20.63, 20.5. (ES1+) calcd for 
C25H40N4O9 [M+H]+, 541.6 found 541.3.
Compound 11:
The pure compound (11) was obtained as a white solid with 0 .114g (81%), m.p. 143.0-
145.0 °C. 'H  NM R (400 MHz, CDC13): 7.69(s, 1H), 7.13 (d, 1H, J  = 8.5 Hz), 6.08 (d, 
1H, 7 = 9 .3  Hz), 5.47 (t, 1H, J  = 9.37Hz), 5.25 (t, 1 H ,J = 9 .3  Hz), 4.62 (q, 1 H ,J = 9 .3  
Hz), 4.27 (dd, 1H, J =  9.37, 4.68 Hz), 4.12(m, 1H), 4.03(m, 1H), 2.67 (br, s, 2H), 2.33 
(br, s, 2H), 2.05 (m, 9H), 1.75 (s, 3H),1.61 (m, 6 H), 1.29 (m, 10H). 13C (100 MHz, 
CDCI3+CD3OD): 5 189.0, 175.1, 147.8, 174.5, 173.5, 118.2, 89.7, 78.6, 72.0, 65.7, 56.9,
32.1, 28.9, 26.1, 24.4, 24.35, 24.30. (ESI+) calcd for C 25H38N40 ,o  [M+H]+, 555.6 found
555.5.
Compound 12:
The pure compound (12) was obtained as a white solid with 0.104 g (82 %), m.p. 281.0-
283.0 °C. 'H  NM R (400 MHz, CDC13): 8.15 (s, 1H), 7.83 (d, 2H, J =  7.0 Hz), 7.41(m, 
2H), 7.34 (m, 1H), 6.67 (d, 1H, J =  9.3 Hz), 6.15 (d, 1H, J =  10.1 Hz), 5.55 (t, 1H, J  =
9.3 Hz), 5.27 (t, 1H, J  = 9.3 Hz), 4.68 (q, 1H, J  = 9.3 Hz), 4.30 (dd, 1H, J  = 4.6, 9.3 Hz), 
4.15 (m, 1H), 4.03 (m, 1H), 2.05 (m, 9H), 1.73 (s, 3H). I3C (100 MHz, CDCI3): 8  170.7,
170.6, 69.3, 129.8, 128.8, 128.5, 125.8, 85.8, 74.9, 72.3, 68.0, 61.6, 53.4, 35.1, 22.7, 
20.67,20.61, 20.5. (ESI+) calcd for C22H26N 40 8  [M+Na]+, 497.1 found 497.1.
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Compound 13:
The pure compound (13) was obtained as a white solid with 0.106 g (77%). m.p. 200.0-
202.0 °C. 'H  NM R (400 MHz, CDCI3): 7.63 (s, 1H), 7.28-7.19 (m, 5H), 6 .6 6  (d, 1H, 7  =
9.3 Hz), 6.06 (d, 1H ,7  = 10.1 Hz), 5.52 (t, 1H, 7  = 9.3 Hz), 5.21 (t, 1H, 7 = 9 .3  Hz), 4.60 
(q, 1H, 7  = 9.3 Hz), 4.28 (dd, 1H, 7  = 4.6, 9.3 Hz), 4.13 (m, 1H), 4.02 (m, 1H), 2.73 (t, 
1H, 7  = 7.8 Hz), 2.65 (t, 1H, 7  = 7.8 Hz), 2.06 (s, 3H), 2.05 (m, 9H), 1.74 (s, 3H). I3C 
(100 MHz, CDCI3): 6  170.6, 170.56, 170.52, 169.3, 128.4, 128.3, 125.8, 85.6, 74.7, 72.3,
68.1, 61.7, 53.2, 35.1, 30.7, 25.0, 22.7, 20.6. (ESI+) calcd for C 25H32N 4O 8 [M+H]+, 517.5 
found 517.2.
Compound 14:
The pure compound (14) was obtained as a white solid with 0.112 g (87 %), m.p. 212.0-
214.0 °C. 'H  NMR (400 MHz, CDC13): 7.61 (s, 1H), 6.73 (d, 1H, 7  = 9.3 Hz), 6.07 (d, 
1H, 7  = 10.1 Hz), 5.53 (t, 1H, 7 = 9 .3  Hz), 5.21 (t, 1H, 7 = 9 .3  Hz), 4.59 (q, 1 H ,7 = 9 .3  
Hz), 4.28 (dd, 1H, 7  = 4.6, 9.3 Hz), 4.12 (m, 1H), 4.03 (m, 1H), 2.73 (t, 1H, 7  = 7.8 Hz), 
2.69 (t, 1H, 7 =  7.8 Hz), 2.05 (m, 9H), 1.75 (s, 3H),1.64 (m, 2H), 1.29 (m, 6 H), 0.86 (t, 
3H, 7 =  7.0 H z). 13C (100M H z, CDC13): 6  170.6, 170.5, 169.3, 148.7, 120.0,85.5 ,74.7 ,
72.3, 68.1, 61.7, 53.2, 31.5, 29.0, 28.8, 25.5, 22.7, 22.5, 20.67, 20.62, 20.5, 14.0. (ESI+) 
calcd for C22H26N 2O2 [M+Na]+, 505.5 found 505.2.
Compound 15:
The pure compound (15) was obtained as a white solid with 0.121 g (84 %), m.p. 174.0-
176.0 °C. 'H  NMR (400 MHz, CDC13): 7.61 (s, 1H), 6 .8 8  (d, 1H, 7 =  8.5 Hz), 6.09 (d,
87
1H, J  = 10.1 Hz), 5.54 (t, 1H, .7= 9 .3  Hz), 5.21 (t, 1H, .7= 9 .3  Hz), 4.59 (q, 1H, .7= 9 .3  
Hz), 4.28 (dd, 1H, .7= 9.3, 4.6 Hz), 4 .12(m , 1H), 4.03 (m, 1H), 2.73 (t, 1H, .7= 7.8 Hz), 
2.67 (t, 1H, J =  7.8 Hz), 2.05 (m, 9H), 1.74 (s, 3H),1.64 (m, 2H), 1.24 (m, 16H), 0.86 (t, 
3H, J  = 7.0 Hz). 13C (100 MHz, CDC13): 8 170.6, 170.5, 169.3, 148.7, 120.0, 85.5, 74.7,
72.3, 68.2, 61.7, 53.2, 31.8, 29.6, 29.57, 29.5, 29.3, 29.2, 29.1, 25.5, 22.6, 14.0. (ESI+) 
calcd for C22H 26N 2O2 [M+Na]+, 561.6 found 561.2.
Compound 16:
The pure compound (16) was obtained as a white solid with 0.121 g (76 %), m.p. 180.0-
182.0 °C. 'H  NM R (400 MHz, CDC13): 7.69 (s, 1H), 5.94 (d, 1H, J =  8.5 Hz), 5.77 (d, 
1H, 7 =  9.3 Hz), 5.41 (t, 1H, J =  10.1 Hz), 5.23 (t, 1 H ,7 =  10.1 Hz), 4.59 (q, l H , / =  10.1 
Hz), 4.27 (dd, 1H, J =  9.3, 4.6 Hz), 4.12 (m, 1H), 4.03 (m, 1H), 2.70 (t, 2H, J =  7.8 Hz),
2.05 (m, 9H), 1.75 (s, 3H), 1.66 (m, 2H), 1.60 (m, 2H), 1.26 (m, 20H), 0.88 (t, 3H, J  = 7.0 
Hz). I3C (100 MHz, CDCI3): 8  170.6, 170.56, 175.0, 169.3, 148.8, 119.9, 85.6, 74.7, 72.3,
68.1, 61.7, 53.2, 31.8, 29.61, 29.6, 29.3, 29.2, 29.1, 25.5, 22.7, 22.6, 20.67, 20.63,14.0. 
(ESI+) calcd for C22H26N2O 2 [M + N af, 617.7 found 617.3.
Compound 17:
The pure compound (17) was obtained as a white solid with 0.155g (6 8 %), m.p. No 
characteristic melting point. At 300.0 °C turn into black char. 'H  NMR (400 MHz, 
CDCl3+M e3OD): 7.74 (br, s, 2H), 7.65 (d, 2H, J =  8.5 Hz), 5.88 (d, 2H, J  = 10.1 Hz), 
5 .33(t,2H , J =  9.3 Hz), 5.12 (t, 2H, J =  9.3 Hz), 4.44 (q, 2H, J =  9.3 Hz), 4.20 (dd, 2H, J  
= 9.3, 4.6 Hz), 4.05 (m, 2H), 3.94 (m, 2H), 2.65 (m, 4H), 1.97 (m, 18H), 1.63(m, 10H).
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13C (100 MHz, CDCl3+M e3OD): 6 171.1, 170.8, 170.6, 169.55, 128.4, 128.3, 126.9, 83.7,
74.6, 72.3, 68.0, 61.7, 52.9, 28.1, 22.1, 20.5, 20.3. (ESI+) calcd for C36H5oN80 , 6 
[M+Na]+, 873.8 found 873.2.
Synthesis o f sugar azide (20):
o  oAA
H B r-A cO H  
rt, 1 1 h
O A cO A c
N aN
D M F, 7 0  °C A cOA cO
19
Ni
500 mL RBF charged with a-D-Glucose (18) (5.0 g, 27.0 mmol) to this 25 mL o f Acetic 
anhydride was added. 5 mL o f HBr-AcOH was added to the reaction mixture and stirring 
continued for for 5 h at rt. After 5 h added additional 25 mL o f HBr-AcOH to the 
reaction mixture and stirring continued for additional 6 h. Then 100 mL o f DCM was 
added to the reaction mixture and poured into ice cold water. DCM layer was separated. 
Then water layer extracted with DCM (2x20 mL). Combined organic layers were 
quenched with saturated N aH C 03 and organic layer was washed with brine, dried over 
anhydrous N a3S0 4  and concentrated. Product was recrystallized from THF-Hexanes 9.8 g 
product (85.88 %).
To a solution o f  2,3,4,6-tetra-O-acetyl-a-D -glucopyranosyl bromide (5 g, 12.15 mmol, 1 
equiv) was dissolved in dry DMF (25 mL). To this solution NaN3 (2.37 g, 36.45 mmol, 
3 equiv). The reaction mixture was stirred at 70 °C under nitrogen for 4h. Reaction was
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monitored using TLC and LC-MS, after completion crude product was washed with 
water and extracted with ethyl acetate (100 mL). Organic layer was dried over anhydrous 
Na2S0 4  and concentrated. The crude product was purified by column chromatography 
with Hexane: EtOAc (15:85) to get the desired product 2,3,4,6-tetra-O-acetyl-P- D -  
glucopyranosyl azide (20) (3.67 g, 81% yield) as white crystals. The pure compound was 
obtained as a white solid with 3.67 g (81 %), m.p. 124.0-126.0 °C. 'H NMR (400 MHz, 
CDC13): 8  5.21 (dd, 1H, J  = 9.2, 9.6 Hz), 5.11 (dd, 1 H ,J = 9 .2 , 10 Hz), 4.95 (dd, 1H, J  =
8 .8 , 9.6 Hz,), 4.64 (d, 1H, J =  8 .8  Hz), 4.27 (d d , , 1H, .7= 4 .8 , 12.4 Hz), 4.16 (dd, 1H, J  
= 2.4, 12.4 Hz), 3.79 (ddd, 1H, J =  2.4, 4.8, 10 Hz), 2.10 (s, 3H), 2.07 (s, 3H), 2.02 (s, 
3H), 2.00 (s, 3H,). 13C NM R (100 MHz, CDCI3): 5 (ppm) 170.5 , 170.0, 169.3,
169.2,169.1, 87 .8 ,73 .9 ,72 .5 , 70 .5 , 67 .7 , 61.5, 20.5.
General procedure for the synthesis o f Triazoles:
To a 50 mL o f round bottom flask 100 mg o f compound (20) (100 mg, 0.26 mmol) and 
10-Undecynoic acid (125 mg, 0.69mmol) were dissolved in tBuOH:THF:Water: 1:1:1 (6  
mL). To this solution copper (II) sulfate (17 mg, 0.106 mmol) and L-Ascorbic sodium salt 
(42 mg, 0.212 mmol) were added. Reaction was kept at room temperature for 14h. 
Reaction was monitored using TLC and LC-MS, shows the conversion by this time. The 
solvents were evaporated under reduced pressure. The resulting residue was dissolved in 
chloroform (10 mL), washed with water (2 mL) and the extracted crude product was 
purified using flash chromatography DCM:MeOH ( 95:5) to get the desired product 
(compound 21) as white solid with 0.131 g with 78%.
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Compound 21:
The pure compound (21) was obtained as a white solid with 0 .13lg  (78%), m.p. 143.0-
145.0 °C. 'H  NM R (400 MHz, CDC13): 5 7.49 (s, 1H), 5.84 (m, 1H), 5.38 (m, 2H), 5.20 
(m, 1H), 4.26 (dd, 1H, J =  12.4, 5.4 Hz), 4.30 (dd, 1H, 7  = 12.4, 5.4 Hz), 4.09 (dd, 1H, 7  
= 12.4, 2.4 Hz), 3.98 (m, 2H), 2.66 (t, 2H, 7  = 7.8 Hz), 2.29 (t, 2H, 7  = 7.8 Hz), 2.04 (s, 
3H), 2.02 (s, 3H), 1.98 (s, 3H), 1.82 (s, 3H), 1.59 (m, 2H), 1.27 (m, 8H). 13C (100 MHz, 
CDCh): 5 178.7, 170.5, 169.9, 169.4, 168.9, 149.0, 118.8, 85.6, 74.9, 72.6, 70.1, 67.7,
61.5, 33.9, 29.0, 28.97, 28.93, 28.9, 25.4, 24.6, 20.6, 20.0. (ESI+) calcd for C25H37N30 n  
[M+H]+, 556.5 found 556.2.
Compound 22:
The pure compound (22) was obtained as a white solid with 0.102 g (86 %), m.p. 158.0-
160.0 °C. 'H  NMR (400 MHz, CDC13): 8 7.66 (s, 1H), 5.84 (d, 1H, 7  = 9.3 Hz), 5.43 (t, 
1H, 7 = 8 .5  Hz), 5.36 (t, 1 H ,7 = 9 .3  Hz), 5.23 (t, 1 H ,7 = 9 .3  Hz), 4.31 (dd, 1H ,7  = 12.4,
5.4 Hz), 4.16 (dd, 1H, 7 =  12.4, 1.5 Hz), 4.00 (m, 1H), 3.92 (m, 2H), 2.96 (m, 2H), 2.09 
(s, 3H), 2.07 (s, 3H),2.03 (s, 3H), 1.88 (m, 3H). I3C (100 MHz, CDC13): 8 170.4, 169.8,
169.3, 169.1, 146.2, 120.23, 85.7, 75.1, 72.4, 70.5, 67.7, 28.7, 20.6, 20.5, 20.4, 20.1. 
(ESI+) calcd for C,8H25N 3O io [M+H]+, 444.4 found 444.1.
Compound 23:
The pure compound (23) was obtained as a white solid with 98 mg (85 %), m.p. 153.0-
155.0 °C. 'H  NMR (400 MHz, CDC13): 8 7.78 (s, 1H), 5.88 (m, 1H), 5.43 (m, 2H), 5.24 
(m, 1H), 4.81 (s, 2H), 4.30 (dd, 1 H , 7 =  12.4, 5.4 Hz), 4.15 (dd, 1 H , 7 =  12.4, 5.4 Hz),
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4.00 (m, 1H), 2.07 (s, 3H), 2.06 (s, 3H), 2.03 (s, 3H), 1.89 (m, 3H). I3C (100 MHz, 
CDC13): 6  170.5, 169.9, 169.3, 169.0, 148.5, 120.2, 85.6, 75.0, 72.6, 70.3, 67.6, 61.5,
56.3, 20 .6 ,20 .4 ,20 .1 . (ESI+) calcd for C 17H23N 3O 10 [M+Na]+, 452.3 found 452.1.
Compound 24:
The pure compound (24) was obtained as a white solid with 0.127 g (8 8 %), m.p. 178.0-
180.0 °C. 'H  NM R (400 MHz, CDCI3): 6  7.70 (s, 1H), 5.86 (m, 1H), 5.41 (m, 2H), 5.24 
(m, 1H), 4.30 (dd, 1 H , J =  12.4,5.4 Hz), 4.30 (dd, 1 H , J =  12.4,5.4 Hz), 4.14 (dd, 1H, J  
= 12.4, 2.4 Hz), 4.00 (m, H), 2.08 (s, 3H), 2.06 (s, 3H), 2.02 (s, 3H), 1.95 (m, 2H), 1.85 
(m, 2H), 1.74 (m, 2H), 1.56 (m, 2H), 1.37 (m, 1H). 13C (100 MHz, CDCI3): 5 170.4,
169.8, 169.3, 168.8, 156.2, 118.1, 85.6, 75.0, 72.5, 70.2, 69.4, 67.7, 61.5, 37.9, 25.2, 21.8,
20.6, 20.4, 20.0. (ESI+) calcd for C 22H 31N 3O 10 [M+H]+, 498.5 found 498.3.
Compound 25:
The pure compound (25) was obtained as a white solid with 0.120g (83 %), m.p. 188.0-
190.0 °C. 'H  NMR (400 MHz, CDC13): 8  7.72 (s, 1H), 6.02 (m, 2H), 5.42 (t, J  = 9.37 
Hz, 1H), 5.23 (t, J  = 9.37 Hz, 1H),4.60 (m, 1H) , 4.29 (dd, J  = 9.37,4.68 Hz, 1H), 4.14 
(m, 1H), 3.97 (m, 1H), 3.63 (m, 2H), 2.70 (m, 2H), 2.07 (m, 9H), 1.79-1.60 (m, 8 H), 1.56 
(m, 2H), 1.31 (m, 10H).I3C (100 MHz, CDC13): 5 170.4,169.8, 169.3, 168.8, 149.1,
118.7, 85.5, 75.0, 72.7, 70.1, 67.7, 62.8, 61.5, 32.7, 29.3, 29.2, 29.1, 29.0, 25.6, 25.2,
20.6, 20.1. (ES1+) calcd for C 25H39N 3Oio[M +H]+, 542.6 found 542.3.
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Compound 26:
The pure compound (26) was obtained as a white solid with 0.129 g (81 %), m.p. 180.0-
182.0 °C. 'H  NMR (400 MHz, CDC13): 7.49 (s, 1H), 5.86 (m, 1H), 5.41 (m, 2H), 5.22 
(m, 1H), 4.30 (dd, 1H, J =  12.4,5.4 Hz), 4.30 (dd, 1 H , J =  12.4,5.4 Hz), 4.14 (dd, 1 H , J  
= 12.4, 2.4 Hz), 3.98 (m, H), 2.70 (t, 2H, J =  7.8 Hz), 2.07 (s, 3H), 2.05 (s, 3H), 2.02 (s, 
3H), 1.86 (s, 3H), 1.65 (m, 2H), 1.56 (m, 24H), 0.86 (t, 3H, J  = 7.8 Hz). 13C (100 MHz, 
CDCI3): 8  1704, 169.8, 169.3, 168.8, 149.2, 118.6, 85.6, 75.0, 72.7, 70 .1 ,67 .7 ,61 .5 ,31 .8 ,
29.6, 29.5, 29.3, 25.6, 22.6, 20.6, 20.5, 20.1, 14.0. (ESI+) calcd for C22H31N 3O 10 [M+H]+,
498.5 found 498.3.
Compound 27:
The pure compound (27) was obtained as a white solid with0.170 g (74 %), m.p. 162.0-
164.0 °C. ‘H NM R (400 MHz, CDC13): 7.54 (br, s, 2H), 5.84 (m, 2H), 5.41 (m, 4H), 5.23 
(m, 2H), 4.29 (m, 2H), 4.14(m, 2H), 3.98 (m, 2H), 2.73 (m, 4H), 2.06(m, 12H), 2.02 (m, 
6 H), 1.86 (m, 6 H), 1.73 (m, 4H). 13C (100 MHz, CDC13): 6  170.4, 169.8, 169.3, 168.9,
148.6, 119.0, 85.5, 74.9, 72.6, 70.1, 67.6, 61.5, 31.1, 28.3, 27.7, 25.2, 20.6, 20.5, 20.1. 
(ES1+) calcd for C36H48N6O 18 [M+H]+, 853.8 found 853.3.
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CHAPTER 4
SYNTHESIS AND CHARACTERIZATION OF a-O-BENZYL D- 
GLUCOSAMINE DERIVATIVES AS ORGANO/ HYDRO GELATORS
4.1. INTRODUCTION
The study o f  small molecular gels has developed into a well-recognized field in materials 
science, pertaining to the general area o f soft matter. Low molecular weight 
organogelators are a new class o f materials that can form gels in organic solvents or 
water. 1'2a'c The main driving forces for the small molecules to aggregate through 
supramolecular interactions are such as hydrogen bonds, n-K interactions, coordination 
bonds and van der Waals interactions. Tuning o f these characteristics has been 
accomplished by using mechanical, thermal, electrochemical and electromagnetic stimuli. 
Hydrogelators have potential applications in biomedical research as scaffolds for tissue 
engineering, drug delivery carriers, protein immobilization and separation.131' 136
Carbohydrates based gelators have drawn a lot o f  attentions in recent years. We have 
been working on the design, synthesis and analysis o f monosaccharide based, self­
assembling systems and the study o f their gelation properties.137' 155 We have previously 
shown that monosaccharide derivatives can form effective low molecular weight gelators 
for both organic solvents and aqueous mixtures.23'24 Several classes o f monosaccharide 
derivatives have been found to be excellent hydro/organo gelators. These include various 
alpha-methoxy4,6-benzylidene acetal protected glucose and glucosamine derivatives.
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Among the modifications on the basic skeletons, a series o f analogs including esters, 
carbamates, amides, and urea derivatives have shown to be able to form effective 
gelators. We have found previously that amides and ureas are more efficient gelators as
that having an extra hydrogen bonding group like amide and urea increase the gelation 
property in certain kind o f organic/water mixtures .
F igure 44. Different head groups o f monosaccharides derivatives o f  sugars.
To further explore and to increase the gelation property o f amides and ureas as compared 
to methoxy group at the anomeric position, we changed the anomeric position with a-O - 
benzyl glycoside o f D-glucosamine to give the compound 4.
4.2. R ESU LTS AND DISCUSSIONS
In this research, we have studied the gelation capability o f  a series o f glucosamine 
derivatives using compound 4 as the head group. As shown in Schem e 18, a series o f 
amide and urea derivatives were synthesized and screened for their gelation properties in 
several solvents. The synthesis and structure and gelation relationship are reported here. 
In order to find out the effect o f the anomeric configuration towards gelation, we
compare to the corresponding esters and carbamates,24'25 as it is now clearly understood






synthesized analogs using the a-O-benzyl glucosamine 4 as the head group, the synthesis 
and gelation results are discussed here. The choice o f the functional groups is based on 
the previous study, so that we may be able to fine tune or modulate the gelation property 
by changing anomeric position o f the sugar ring.
Schem e 17. Synthesis o f  a-O-benzyl glycoside o f D-glucosamine head group
,X, O'"
HO'
HO“r 7 ^ r >  c h 3c o o h





90 °C, 5h 
86%
3N NaOH in 
EtOH
3
85 °C, 48h 
7 8 %
HO.




0 °C, 5h 
65 - 85  %
HO.
R -N C O
HOTHF, 0 °C to rt, 5h 
80-90 % NH X  0=< °v.
Hl? PI,
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The systematic change will allow us to understand how the benzyl group will affect the 
assembling process which in turn, affecting the gelation properties. From our previous 
research, the -OMe group apparently played a positive role in the gelation process. By 
attaching an O-benzyl group at anomeric position, this will allow us to understand what 
functional groups will be tolerated on the basic gelator system.
The amide reactions generally proceeded with good yields and ureas were obtained in 
close to quantitative yields. The product can be purified on silica gel by flash chromato­
graphy using a polar solvent. The structures o f the amide and urea synthesized and their 
gelation properties are shown in tables 5 and 6. The selection o f the R groups for ureas
• 13and amides are based on our previous research and the availability o f starting materials. 
These include compounds with saturated alkyl chains, cyclohexyl and aromatic group. 
From the screening o f  the gelation results o f  these compounds, we can determine how the 
structure o f the alkyl or aryl groups affects self-assembling. The urea analogs showed 
gelation tendencies more than the amides, with the alkyl chain derivatives with 5-7 
carbons being most versatile gelators for organo/aqueous mixtures.
The amide derivatives compound 6-8 formed gels in EtOFl/FbO (1:2) and DMSO/ F^O 
(1 :2). But the aryl containing compounds are not as effective as compared to the urea 
derivatives. Compounds 15 and 16 formed organogels in EtOH/water and DMSO/water 
at concentrations lower than 2 mg/mL as shown in table 6. A photo o f the gel formed by 
15 is shown in figure 45.
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Table 5. Gelation test results o f amide compounds





H O A - ' - J - 'A
nh4
Ph
I I G 6.6 G 10 G 2.5
3
'4 h,
I I G 6.6 G 10.0 G 2.5
6 I I G
10.0
G 2.5 G 2.0
7 I I G 6.6 G 2.5 G 2.0
8 I I G 5.0 G 2.0 G 5.0
9 I I G 5.0 G 4.0 P
10 Br^ ^ v I I G 6.6 P G 6.6
11 rO I P G 6.6 G 5.0 G 20.0
12 I I G 6.6 G 2.0 UG 20.0
G, gel at room temperature, the numbers are the corresponding minimum gelation 
concentrations (MGCs) in mg mL; I, insoluble; P, precipitating; S, soluble at ~ 20 mg 
m L '1; the ratios for mixed solvents are volume : volume ratios.
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Table 6. Gelation test results o f urea compounds




I I G 1.6 G 2.2 G 2.5
14 I I G
20.0
G 2.5 G 2.2
15 I I G
20.0
G 2.0 G 1.33





G 5.0 G 10.0
G, gel at room temperature, the numbers are the corresponding minimum gelation 
concentrations (MGCs) in mg mL; I, insoluble; P, precipitating; S, soluble at ~ 20 mg 
m L '1; the ratios for mixed solvents are volume : volume ratios.
F igure 45. A photographs o f a gel by compound 15 in EtOH: Water / 1:2 in 1.33 mg/ mL.
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We analyzed several gels in their gel states using optical microscopy, in an attempt to 
reveal the supramolecular assembly o f the gels with the solvents still trapped inside. The 
dried xerogels were also studied by optical microscopy. These results are shown in 
figures 46, 47 and 48. The gel o f 11 in ethanol/water showed bundled fibrous assemblies, 
as shown in figure 46. At lower magnification, we can see the long fibers floating in the 
gel solvent matrix. The optical micrographs o f the xerogels gels formed by compounds 6 
and 13 are shown in figures 47 and 48.
Figure 46. Optical micrographs (A. B. C.D) and. gel o f compound 11 in EtOH / H^O 








Figure 47. Optical micrographs (E. F. G) and. gel o f compound 6 in EtOH /H 2O (1 :2) at
2.5 mg/mL, at 60x and lOOx magnifications.
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Figure 48. Optical micrographs (H. I.) and. gel o f compound 13 in EtOH / H2O (1:2) at 
2.5 mg/mL. at 60x magnifications.
The gelation o f alkyl chain urea and amide compounds were studied in three different 
concentrations. We also studied the minimum gelation concentration o f  compounds 
formed in E t0H /H 20 (1:2) solvents. Like others LMOGs, gelators 13 and 14 gelatinized 
these solvents through non covalent interactions and thus the thermally reversible gel-to- 
sol phase transition is a characteristic feature o f  the resultant gels. To compare their 
thermal properties, studied the gel-sol phase transition temperatures. Tgei. upon the 
gelator concentration o f compounds 6. 7, 14 and 15 as shown in figure 49. Compared the 
stability o f hydrogel for amide and urea compounds. Urea derivatives have higher Tgel 
compared to the amide derivatives, from this we can assume that the hydrogen bonding 













Fig 49. Dependence o f the gel-sol phase transition. Tge|. upon the gelator concentration.
We have studied the dynamic rheology properties o f amide derivatives as shown in 
figure 50. the dynamic moduli G' and G" are shown as a function o f angular frequency w 
at their minimum gelation concentrations for compounds 6. 7, 8 and 9. As shown in 
figure 50. the storage modulus G' is greater than the Loss modulus G '' for all these 
compounds and these compounds have high shear stress. The fact that G’ is greater than 
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Figure 50. Viscoelastic properties o f amides derivatives 1) compound 6 in DMSO: 
Water: 1:2 in 2.5 mg/ mL 2) compound 7 in DMSO: Water: 1:2 in 2.5 mg/ mL 3) 
compound 8 in DMSO: Water: 1:2 in 2.0 mg/ mL 4) compound 9 in DMSO: Water: 1:2 
in 2.0 mg/mL.
We have also studied the dynamic rheology properties o f urea derivatives shown in 
figure 51. The dynamic moduli G' and G ” are shown as a function o f angular frequency 
(o at their minimum gelation concentrations for compounds 13. 16 and 17. The storage 
modulus G' is greater than the Loss modulus G" for all these compounds and these 
compounds have high shear stress. The fact that G1 is greater than G" is an indication that 
the gels are elastic semisolid. These compounds have higher G' and G" value than amide. 
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Figure 51. Viscoelastic properties urea derivatives 1) compound 13 in DMSO: Water:
1:2 in 2.2 mg/ mL 2) compound 16 in DMSO: Water: 1:2 in 2.2 mg/ mL 3) compound 17 
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Figure 52. !H NMR spectra’s for compound 6  at different concentration (each spectrum 
in 0.5 mL o f CDCI3).
To study the hydrogen bonding effect for the organo gelation, we have choosen 
compound 6  for this study. For this study four different concentrations from 4, 8  and 16 
mg in 0.5 mL o f CDCI3 were studied. All the signal are almost same except at the NH- 
bond in amide at 5.8 ppm in the NM R signal shifted slighly downfield at 32 mg/mL 
concentration, as shown in figure 52. It shows that at higher concentration the molecules 
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Figure 53. 'H NM R spectra’s for compound 8 ( 8  mg in 0.5 mL CDCI3) at different 
temperatures.
We have aslo studied the hydrogen bonding effect for the gelation at different 
temperature. We have choosen one o f the amide compound (8 ) for this study. From the 
figure 53 shows that there is a slight change o f NH absorption when incresing the 
temperature from 20 °C to 60 °C. All the signals are almost same except at the NH-bond 
in amide at 5.8ppm in the NM R signal shifted to upfield slightly This indicated that 
hydrogen bonding will effect the gelation property by varying the concentration and 












Figure 54. Proposed hydrogen bonding model for compound 8.
For all these compounds the purity was tested by 'H  NMR, l3C NMR spectra and LC- 
MS. For few compounds spectra’s were shown in figure 54 and 55. Their chemical shift 
values were discussed in experimental section.
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‘H NMR spectra (400 MHz, C D C I3) and ,3C NMR spectra (100 MHz, C D C I3): 
Compound 4:
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In summary, we have designed and synthesized a series o f  alpha-O-benzyl glycoside o f 
N-acetyl glucosamine analogs and obtained several effective organo/hydrogelators. In 
general, urea derivatives showed better gelation than amides. We have also studied the 
hydrogen bonding effect by varying temperature and concentration These organo/hydro 
gelators found in the current research can be explored for further applications in several 
systems. Future studies include the exploration o f  their effectiveness in enzyme 
immobilization, designing analytical tools to understanding molecular interactions, and as 
matrix for delivery o f biological agents.
4.4. EXPERIM ENTAL SECTION  
General Methods
All reactions, unless otherwise noted were carried out in oven dried glassware under 
nitrogen atmosphere. All the reagents and solvents were obtained from Sigma-Aldrich, 
VWR, and Fisher. Flash chromatography was carried out using silicycle 230-400 mesh 
silcagel. Thin-layer chromatography (TLC) analysis was performed with Merck Kieselgel 
60 F 254 plates, and visualized using UV light. 'H  NM R and proton-decoupled 13C NMR 
spectra were obtained with Varian 400 MHz spectrometer in CDCI3 with TMS as an 
internal standard. Proton and carbon spectra chemical shifts were reported using TMS 
and CDCI3 as internal standard at 0 ppm and at 77.00 ppm, respectively. Melting point 
was measured using fischer scientific instrument.
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Gelation Testing: The compounds were tested in a 1 dram vial with a rubber lined screw 
cap from Kimble. A starting concentration o f  20 mg/mL was used (2mg in 0.1 mL). The 
suspension was heated to dissolve the compound (a homogeneous solution) and 
sonicated, if  necessary. The solution was allowed to cool for 15-20 minutes. If a stable 
gel formed, 0.2-0.3 mL o f the same solvent (or solvent mixture) was added and the 
heating/sonication and cooling was repeated. The process was repeated until the gel was 
no longer stable and the concentration prior to the unstable gel was recorded as the 
minimum gelation concentration (MGC).
Optical Microscopy: The slides were prepared after a stable gel has formed. About small 
amount o f the gel was placed on a clean 3 by 1 inch glass slide and dried overnight to 
several days. The xerogels were observed with an Olympus BX60M optical microscope 
using a DSP Color Hi-Res EXvision camera and an Olympus U-TV1X lens. The program 
used to acquire and store the photos was Corel Photo-Paint 7.
Synthesis o f b enzyl-4,6-0-benzylidene-2-deoxy-2-am ino-a-D-glucopyranoside (4):
A-Acetyl-D-glucosamine 1 (2.0 g, 9.04 mmol) and p-toluene sulfonicacid (0.17 g, 0.9 
mmol) were dissolved in 20.0 mL o f toluene and 10 mL o f benzyl alcohol. The reaction 
mixture was refluxed in a dean-stark apparatus with water removal by azeotropic 
mixture. After 12h, the solvent were removed under reduced pressure. Hexane: EtOAc 
(10:1) (20 mL) was added to the oily residue and stirred vigorously for 3h. The 
amorphous precipitate was filtered off, washed with hexane and the crude product was
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recrystallized from ethanol to yield a colorless solid (2.31 g, 82 % yield). Benzyl 2- 
acetamido-2-deoxy-a-D-glucopyranoside ( lg , 3.23 mmol) was dissolved in anhydrous
6.0 mL o f DMF, followed by benzaldehyde dimethyl acetal (0.6 mL, 3.87 mmol) and p- 
toluenesulfonic acid (0.055 g, 0.323 mmol) were mixed and heated at 90°C for 5hrs. 
After 2h and 4h excess methanol produced was removed under reduced pressure. 
Reaction was completed after 5h, reaction was quenched with N aH C 03 and stirred the 
solution at room temperature for 30 min. Filtered the salt and DMF was removed under 
reduced pressure, the crude mixture was purified by recrystallization in isopropanol to 
get the desired product compound 3 as (1.1 g, 86%) white solid. Compound 3 ( lg )  was 
then dissolved in 25 mL o f refluxing 3N KOH ethanol for 18 hours. Reaction was diluted 
with DCM (-3 0  mL) and water (2x20 mL). After drying the DCM layer over anhydrous 
sodium sulphate, the crude product was purified by column chromatography using 2% 
MeOH in DCM to get the desired as white solid with (0 .7 lg , 79% ).
The pure compound 4 was obtained as a white solid with 79% yield m.p. 177.0-179.0 °C. 
'H  NMR (400 MHz, CDC13): 6 7.53-7.46 (m, 2H), 7.42-7.29 (m, 8H), 5.53 (s, 1H), 4.90 
(d, 1H, J  -  3.7 Hz), 4.74 (d, 1H, J  = 11.8 Hz, C //2Ph,), 4.52 (d, 1H, J =  11.8, CH2?h), 
4.23 (dd, 1H, J  = 4.8, 10.3 Hz), 3.88 (ddd-dt, 1H, J  = 4.8, 9.5, 9.9 Hz), 3.76 {pseudo t, 
1H, J =  9.2 Hz), 3.74 {pseudo t, 1H, .7=10.3 Hz), 3.48 (t, 1H, .7=9.2  Hz), 2.81 (dd, 1 H ,J  
= 3.7, 9.5 Hz), 1.98 (brs, 3H). I3C (100 MHz, CDC13): 5 137.2, 137.1, 129.2, 128.5,
128.3, 128.0, 126.3, 101.9, 99.5, 71.7, 69.8, 69.0, 62.9, 56.7.
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General procedure for the synthesis o f amides
To a 50 mL o f round bottom flask 100 mg o f compound (4) head group was dissolved in 
3 mL o f DCM and 3 equivalent o f potassium carbonate or pyridine was added into the 
reaction flask. Cooled the reaction mixture at 0 °C and 1.1 equivalent o f  the 
corresponding acid chloride were added drop wise to the solution. The mixture was left 
stirring for 6-10 hrs, after which the mixture was concentrated under nitrogen. The crude 
residue was purified by flash chromatography using hexane/EtOAc (20:80). The resulting 
purified compound was tested for their gelation activity.
General procedure for the synthesis o f ureas: The urea library was synthesized by 
mixing 100 mg o f compound compound 4 and the corresponding isocyanate in 
stoichiometric quantities in anhydrous THF. The solution was stirred at room temperature 
for 3-5 h. The crude products were purified by flash chromatography on silica gel. 
DCM/MeOH (5%) gradient solvent system was used for the chromatography separation.
Benzyl-4,6-0-benzylidene-2-deoxy-2-Hexynoylamino-a-D-gIucopyranoside (6):
The pure compound was obtained as a white solid with 91 mg (72 % yield), m.p. 178.0-
180.0 °C. 'H  NM R (400 MHz, CDCl3+MeOD): 8 7.52-7.49 (m, 2H), 7.41-7.32 (m, 8H),
5.79 (d, 1H, J  = 8.5), 5.51 (s, 1H), 4.93 (d, 1H, J =  3.9 Hz), 4.75 (d, 1H, J =  11.7 Hz, 
CH2Ph), 4.50 (d, 1 H ,J =  11.7 Hz, CH2Ph), 4.24 ( m, 1H), 3.95 (t, 1H, J=  9.3 Hz), 3.88 
(ddd~dt, 1H, 7 -  4.8, 9.5, 9.9 Hz), 3.77 (pseu dot,  1H, J = 9 .1  Hz), 3.61 (pseudo t, 1H, J  
= 9.1 Hz), 3.41 (s, 3H), 2.18 (t, 2H , J=  7.3 Hz), 1.60 (m, 2H), 1.30 (m, 4H), 0.89 (t, 3H,
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7  = 12  Hz). I3C (100 MHz, CDC13): 5 175.1, 137.2 , 137.0, 129.3, 128.7, 128.4, 128.3,
128.2, 126.4, 102.0, 97.5, 82.2, 70.1, 69.4, 68.9, 63.1, 54.1, 54.0, 36.5, 31.6, 28.9, 25.4,
22.4, 14.0. HRMS (ESI+) calcd for C26H33N 0 6 [M+Na]+, 478.2200 found 478.2199.
Benzyl-4,6-0-benzylidene-2-deoxy-2-Heptanoylam ino-a-D-glucopyranoside (7):
The pure compound was obtained as a white solid with 98 mg (75 % yield), m.p. 188.0-
190.0 °C. 'H  NMR (400 MHz, CDCl3+MeOD): 5 7.52-7.49 (m, 2H), 7.42-7.32 (m, 8 H),
5.78 (d, 1H, .7= 8 .7  Hz), 5.57 (s, lH ),4 .7 5 (d , 1H, 7 = 3 .9  Hz), 4.66 (d, 1H, 7 =  11.7 Hz, 
CH2Ph), 4.50 (d, 1H, 7  = 11.7 Hz, CH2Ph, CH2Ph), 4.24 (m, 2H), 4.06 (t, 1H ), 3.81 (m, 
2H), 3.52 (t, 1H, 7 = 9 .1 5  Hz), 2.25 (t, 2 H ,7 = 7 .3  Hz), 1.57 (m, 2H), 1.21 (m, 6 H), 0.81 
(t, 3H, 7  = 7.2 Hz) ,I3C (100 MHz, CDC13): 6  175.1,137.2, 137.0, 129.3, 128.7, 128.5,
128.4, 128.3, 128.2, 128.0, 126.4, 102.0, 97.5, 82.2, 70.1, 68.9, 63.1, 54.1, 54.0, 36.6, 
36.5, 34.1, 31.6, 25.4, 24.7, 22.6, 14.0. HRMS (E S f)  calcd for Q 7H33NO6 [M+Na]+, 
492.2356 found 492.2347.
Benzyl-4,6-0-benzyIidene-2-deoxy-2-Octanoylamino-a-D-glucopyranoside (8):
The pure compound was obtained as a white solid with 0.105 g (78 % yield), m.p. 196.0-
198.0 °C. ‘H NM R (400 MHz, CDCl3+MeOD): 6  7.52-7.49 (m, 2H), 7.42-7.32 (m, 8 H),
5.78 (d, 1H , 7  -  8.7 Hz), 5.57(s, lH ),4 .7 5 (d , 1H, 7 =  3.9 Hz), 4.66 (d, 1H, 7  = 11.7 Hz, 
CH 2Ph), 4.50 (d, 1H, 7 =  11.7 Hz, CH2Ph, CH2Ph), 4.24 (m, 2H), 4.06 (t, 1H ), 3.81 (m, 
2H), 3.52 (t, 1 H ,7 =  9.15 Hz), 1.58 (m , 2H), 1.28 (m, 8 H), 0.88 (t, 3 H ,7  = 7.0 Hz). I3C 
(100 MHz, CDCI3 + MeOD): 6  175.0, 137.2, 137.0, 129.3, 128.7, 128.4, 128.3, 126.4,
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102.0, 97.5, 82.2, 70.1, 69.5, 69.0, 63.1, 54.0, 36.6, 31.8, 29.3, 29.1, 25.8, 22.7, 14.1. 
HRMS (E S f)  calcd for C28H37N 06 [M+Na]+, 506.2513 found 506.2510.
Benzyl-4,6-0-benzylidene-2-deoxy-2-(5-Hexenoyl)-amino-a-D-glucopyranoside (9):
The pure compound was obtained as a white solid with 90 mg (72 % yield), m.p. 230.0-
232.0 °C. !H NM R (400 MHz, CDCl3+MeOD): 6 7.52-7.45 (m, 2H), 7.40-7.29 (m, 8H),
6.19 (d, 1 H ,7 = 8 .7  Hz), 5.55 (s, lH ),4 .9 0 (d , 1H, 7  = 4.0 Hz), 4.72 (d, 1H, J=  11.7 Hz, 
CH2Ph), 4.46 (d, 1 H ,7  = 11.7 Hz, CH2Ph), 4.19 (m, 2H), 3.87 (m, 2H ), 3.75 (t, 1H, 7  =
9.8 Hz), 3.57 (t, 1H, J =  9.5 Hz), 2.31 (m, 2H), 2.22 (m, 2H), 1.95 (t, 1H, J =  2.6 Hz),
1.80 (m, 2H). 13C (100 MHz, CDC13 + MeOD): 5 174.1, 137.0, 134.7, 129.2, 128.3,
126.3, 101.9, 98.8, 83.4, 82.0, 70.8, 69.3, 68.8, 62.3, 55.3, 53.5, 34.9, 24.2, 24.1, 17.6. 
HRMS (ESI+) calcd for C26H29N 0 6 [M+Na]+, 474.1887 found 474.1884.
Benzyl-4,6-0-benzylidene-2-deoxy-2-(6-Brom ohexanoyl)-am ino-a-D- 
glucopyranoside (10):
The pure compound was obtained as a white solid with 0.125 g (84 % yield), m.p. 184.0-
186.0 °C. 'H  NM R (400 MHz, CDCl3+MeOD): 5 7.52-7.45 (m, 2H), 7.40-7.29 (m, 8H),
6.19 (d, 1H, 7  = 8.7 Hz), 5.55 (s, lH ),4 .9 0 (d , 1H, 7 =  4.0 Hz), 4.72 (d, 1H, 7 =  11.7 Hz, 
CH2Ph), 4.46 (d, 1H, 7 =  11.7 Hz, CH2Ph), 4.19 (m, 2H), 3.87 (m, 2H ), 3.75 (t, 1H, 7  =
9.8 Hz), 3.57 (t, 1H, 7 =  9.5 Hz), 2.12 (m, 2H), 1.75 (m, 2H), 1.51(m, 2H), 1.35 (m, 
2H). ,3C (100 MHz, CDC13+ MeOD): 6 174.2, 136.8, 136.6, 129.0, 128.4, 128.0, 127.9,
126.1, 101.7, 97.2, 81.9, 69.8,69.0, 68.6, 62.8, 53.7, 35.8, 33.4, 32.1, 27.3, 24.4. HRMS 
(ESI+) calcd for C26H32B rN 06 [M+Na]+, 556.1305 found 556.1301.
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BenzyI-4,6-0-benzylidene-2-deoxy-2-Benzoylamino-a-D-glucopyranoside (11):
The pure compound was obtained as a white solid with 0.102 g (82 % yield), m.p. 195- 
197 °C. 'H  NM R (400 MHz, CDCl3+MeOD): 5 7.69-7.64 (m, 2H), 7.49-7.44 (m, 3H), 
7.39-7.34 (m, 3H), 7.36-7.24 (m, 7H), 6.19 (d, 1H , 7  = 8.7 Hz), 5.53(s, 1H), 5.02 (d, 1H, 
7  = 3.6 Hz), 4.72 (d, 1H, 7 =  12.0 Hz, CH2Ph), 4.46 (d, 1H, 7  = 12.0 Hz, CH2Ph), 4.19 
(m ,2H ), 3.87 (m, 2H ), 3.75 (t, 1H, 7  = 9.8 Hz), 3.62 (t, 1H, .7= 9 .5  Hz). 13C (100M H z, 
CDC13 + MeOD): 6 168.8, 137.3, 137.0, 132.0, 129.4, 128.85, 128.80, 128.7, 128.5,
127.3, 127.0, 126.3, 126.5, 102.1, 97.6, 82.3, 70.3, 69.6, 69.0, 63.2, 54.7. HRMS (ESI+) 
calcd for C27H27N 0 6 [M+Na]+, 484.4962 found 484.4958.
Benzyl-4,6-0-benzylidene-2-deoxy-2-Naphthoyalamino-a-D-glucopyranoside (12):
The pure compound was obtained as a white solid with 0.114 g (80 % yield), m.p. 236.0-
238.0 °C. ’H NM R (400 MHz, CDCl3+MeOD): ): 5 7.71-7.67(m, 2H), 7.59-7.49 (m, 
3H), 7.45-7.34 (m, 12H), 6.51 (d, 1H , 7  = 8.7 Hz), 5.59(s, 1H), 5.05 (d, 1H, 7 =  4.0 Hz),
4.78 (d, 1H, 7  = 11.7 Hz, CH2Ph), 4.54 (d, 1H, 7 =  12.0 Hz, CH2Ph), 4.44 (m, 1H), 4.28 
(dd, 1H, 7  = 10.2, 5.1 Hz), 4.08 (t, 1H, 7 = 9 .1  Hz), 3.95 (ddd~dt, 1H, 7  = 5.1, 9.8, 10.5 
Hz), 3.80 (t, 1H, 7  = 10.2 Hz), 3.68 (t, 1H, 7  = 9.5 Hz). i3C (100 MHz, CDC13 + 
MeOD): 5 170.3, 136.6, 137.0, 136.2,133.1, 130.4, 129.5, 128.7, 128.1, 127.8, 127.7,
126.7, 125.9, 125.8, 124.8, 124.7, 124.2, 101.4, 97.4, 81.7, 69.4, 69.5, 68.8, 68.3, 62.6,
54.1. HRMS (E S f)  calcd for C3iH29N 0 6 [M+Na]+, 534.1887 found 534.1883.
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Compound (13):
The pure compound was obtained as a white solid with 0.125 g (92 % yield), m.p. 248.0-
250.0 °C. 'H  NMR (400 MHz, DMSO): 5 7.46 -7.41 (m, 2H), 7.39 -7.31 (m, 4H), 7.32 -
7.25 (m, 4H), 7.14 (t, 1H, J  = 6.2 Hz), 6.73 (d, 1H, J =  8.5 Hz), 5.84 (m, 2H), 5.59 (s, 
1H), 5.30 (d, 1H, J =  3.1 Hz), 4.78 (d, 1H, J =  12.4 Hz, CH2Ph), 4.58 (d, 1H, J  = 8.0 
Hz), 4.50 (d, 1H, J =  12.4 Hz, CH2Ph) 4.22 (dd, 1 H ,J =  10.6, 3.6 Hz), 3.73 (t, 1H, J  =
9.5 Hz), 3.56 (m, 1H), 1.77-1.67 (m, 2H ), 1.66-1.57 (m, 2H ), 1.54-1.47 (m, 2H ), 1.27- 
1.18 (m, 2H ), 1.14-1.00 (m, 2H ). I3C (100 MHz, DMSO): 5 157.0, 137.5, 128.4, 127.9, 
127.6, 127.2, 126.0, 100.5, 97.5, 81.5, 68.3, 67.8, 62.6, 54.5, 47.4, 33.0, 25.0, 24.0. 
HRMS (ESI+) calcd for C27H34N206 [M+Na]+, 505.2309 found 505.2305.
Compound (14):
The pure compound was obtained as a white solid with 0.106 g (77 % yield), m.p. 190.0-
192.0 °C. ’H NMR (400 MHz, DMSO): 5 7.48 -7.45 (m, 2H), 7.42 -7.30 (m, 8H), 6.13 (t, 
1H, J  = 5.4 Hz), 5.82 (d, 1H, J =  8.5 Hz), 4.85 (d, 1H, .7=3.1 Hz), 4.72 (d, 1H, J =  12.4 
Hz, CH2Ph), 4.50 (d, 1H, J =  12.4 Hz, CH2Ph), 4.16 (dd, 1H, J =  3.8, 9.8 Hz), 3.60 (t, 
1H, J  = 8.5 Hz), 3.52 (t, 1H, J  = 8.5 Hz), 2.99 (m, 2H ), 1.37 (m, 2H), 1.27 (m, 6H), 0.83 
(t, 3H, J =  7.0 Hz). ,3C (100 MHz, DMSO): 6175.1, 137.2 , 137.0, 129.3, 128.7, 128.4,
128.3, 128.2, 126.4, 102.0, 97.5, 82.2, 70.1, 69.4, 68.9, 63.1, 54.1, 54.0, 36.5, 31.6, 28.9,




The pure compound was obtained as a white solid with 0.116 g (82 % yield), m.p. 196.0-
198.0 °C. 'H  NMR (400 MHz, DMSO): 6 7.47 -7.41 (m, 2H), 7.39 -7.24 (m, 8H), 6.09 
(m, 1H), 5.79 (d, 1H, J=  3.6Hz), 5.62(s, 1H), 5.23 (d, 2 H ,J  = 3.6 Hz), 4.82 (d, 1H, J  = 
3.6 Hz), 4.70 (d, 1H, J=  9.3 Hz, CH2Ph), 4.47 (d, 1H, J=  9.3 Hz, CH2Ph), 4.13 ( m, 1H 
), 3.71 (m, 3H ), 3.52 (m, 2H), 2.96 (m, 2H ), 1.34 (m, 2H), 1.22 (m, 8H), 0.83 (m, 3H). 
13C (100 MHz, DMSO): 6 175.1,137.2, 137.0, 129.3, 128.7, 128.5, 128.4, 128.3, 128.2,
128.0, 126.4, 102.0, 97.5, 82.2, 70.1, 68.9, 63.1, 54.1, 54.0, 36.6, 36.5, 34.1, 31.6, 25.4,
24.7, 22.6, 14.0. HRMS (ESI+) calcd for C28H38N20 6 [M+Na]+, 521.2622 found 
521.2619.
Compound (16):
The pure compound was obtained as a white solid with 0.118 g (85 % yield), m.p. 234.0-
236.0 °C. 'H  NMR (400 MHz, DMSO): 5 7.45-7.41 (m, 2H ), 7.39-7.32 (m, 7H ), 7.31-
7.26 (m, 3H ), 7.25-7.20 (m, 2H ), 6.60 (t, 1H, J =  5.4 Hz), 5.99 (d, 1H, J =  8.5 Hz), 5.62 
(s, 1H), 5.23 (d, 2H, J  = 5.4 Hz), 4.72 (d, 1H, J  = 11.7 Hz, CH2Ph), 4.50 (d, 1H, J  = 11.7 
Hz, CH2Ph), 4.23 ( m, 2H ), 4.16 (m, 1H ), 3.75 (m, 3H ), 3.61(m, 1H), 3.52 (t, 1H, J  =
8.5 Hz ). ,3C (100 MHz, DMSO): 5 158.1, 140.4, 137.5, 128.7, 128.2, 128.1, 179.9, 
127.58, 127.54, 126.9, 126.5, 126.3, 100.8, 97.8, 81.9, 68.8, 68.5, 68.0, 62.9, 54.9, 42.9. 
HRMS (ESI+) calcd for C28H3oN20 6 [M + N af, 513.1996 found 513.1992.
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Compound (17):
The pure compound was obtained as a white solid with 0.112 g (83 % yield), m.p. 230.0-
232.0 °C. 5 8.72 (s, 1H), 7.47-7.43 (m, 2H ), 7.39-7.32 (m, 7H ), 7.31-7.26 (m, 3H ), 
7.23-7.19 (m, 2H ), 6.90 (t, 1H, 7  = 7.0 Hz), 6.25 (d, 1H, 7  = 8.5 Hz), 5.63(s, 1H), 5.93 
(d, 2H, 7 = 3 .1  Hz), 4.74 (d, IH ,7  = 12.4 Hz, CH2Ph), 4.53 (d, 1 H ,7  = 12.4 Hz, CH2Ph), 
4.17 (dd, 1H, 7 = 8 .5 ,  3.9 Hz), 3.75 (m, 3H ), 3.61(m, 1H), 3.52(t, 1H, 7 =  8.5 Hz ). I3C 
(100 MHz, DMSO): 6 154.8, 140.2, 139.6, 137.5, 128.7, 128.68, 128.61, 127.9, 127.57, 
127.51, 126.3, 121.6, 121.0, 118.0, 117.3, 100.7, 97.7, 81.7, 68.6, 68.3, 67.9, 62.9, 54.8,
54.2, 48.3. HRMS (ESI+) calcd for C27H28N20 6 [M+Na]+, 499.1839 found 499.1836.
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CHAPTER 5
EFFICIENT SYNTHESIS OF ENANTIOPURE SULFINAMIDES AND
SULFINYL KETIMINES
5.1. INTRODUCTION
Chiral amine containing compounds represent an extremely important class of 
compounds in pharmaceutical industry. Chiral sulfinamide mediated chemistry has 
become one o f the most active methods for the synthesis o f compounds containing chiral 
amine functionalities.156' 159 These chiral sulfinamide have potential application in the 
field o f chiral ligands for many catalytic asymmetric transformations.160' 162 Although the 
potential o f chiral sulfinamides has long been recognized, only a few methods have been 
developed for the preparation o f enantiomerically pure /m-butanesulfinamide. Among 
the prominent work on chiral sulfinamide reported by different groups, one o f the 
methods is from the Davis e ta l.163For the synthesis of p-toluenesulfmamide from 
Anderson’s reagent, another method was reported by Ellman and co-workers164a for the 
synthesis o f terr-butanesulfinamide from tert-butyl re/t-butanethiosulfinate, and other 
methods.1646' 166 However, these methods cannot meet the demand for accessing 
sulfinamides with diverse structures, which are required to fine-tune stereoselectivities in 
asymmetric synthesis. To meet this need, soon after the report from the group o f Ellman, 
Senanayake and his group designed and developed a versatile cyclic-oxathiozolidinone- 
based chiral sulfinyl-transfer agent which provides access to a range o f sulfinamides with 
diverse structures (Scheme 19).167
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The accomplishment o f this method based on the recognition that the reactivity o f the 
cyclic oxathiozolidinone 2 could be activated by an electron-withdrawing substituent on 
the nitrogen atom, thus allowing for the facile cleavage o f the sulphur-nitrogen bond to 
provide the desired sulfmate intermediate 3.53a However the reaction conditions required 
for the cleavage o f the sulphur-oxygen bond in 3 to liberate the desired sulfinamides 
relied heavily on the steric bulkiness o f the R substituent.167 While the sulphur-oxygen 
bond could be readily cleaved with LHMDS at 0 °C to room temperature to generate 
some sulfinamides, in the case o f hindered substrates, the use o f excess 
NH2U/NH3 (U/NH3) was required. Currently, NH2U/NH3 is prepared in situ by portion 
wise addition o f a large excess o f solid Li metal to anhydrous N H 3 at reaction 
temperatures o f less than -7 0  ° c .533,167 These reaction conditions, in addition to the safe 
handling and disposal o f waste generated by using NH2Li/NH3, have limited our ability to 
produce these important sulfinamides on large scale. Therefore, the efficient and practical 
synthesis o f sterically hindered chiral sulfinamides remained an unsolved problem in the 
field. By knowing that the steric environment provided by the bulky alkyl or aryl 
substituents o f the sulfinamides is critical for obtaining high stereoselectivities,170'171 it 
was highly necessary to develop a more practical and cost-effective process for their 
synthesis by replacing NH2Li/NH3 with a safer and greener reagent such as LHMDS for 
the final sulphur-oxygen bond cleavage.168 We envisioned that this goal could be 
achieved by tuning the sulphur-oxygen bond reactivity in our cyclic oxathiozolidinone 
templates.
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5.2. RESULTS AND DISCUSSIONS
Herein, we report a new chiral sulfinyl-transfer agent containing a more activated 
sulphur-oxygen bond, from which both sterically hindered enantiopure sulfinamides and 
sulfinyl ketimines were prepared under mild reaction conditions. To identify a template 
with a more reactive sulphur-oxygen bond, the presence o f an electron-withdrawing 
substituent on the phenol ring increased the reactivity, whereas the reactivity was 
attenuated with an electron-donating group. The effect o f sterics on the reactivity o f  the 
sulphur-oxygen bond was also observed.172"179
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It was planned that optically pure 6 could be efficiently accessed on large scale from the 
simple and commercially available chiral aminophenol 5.'79 After screening several 
reaction conditions, it was found that slow addition o f pyridine to a solution o f 5a and 
SOCI2 at -4 0  °C provided the desired product with excellent selectivity. The reaction 
temperature has negligible effect on the selectivity, with minimal erosion o f the d.r. value 
noted when the reaction temperature was increased from -4 0  °C to 0°C. Despite the 
promising profile o f this chiral template, crystallization o f 6a to diastereomerically pure 
material proved highly challenging. Modification o f the sulfonyl group on the nitrogen 
atom did not improve the crystallinity o f 6a. The para-chloro-substituted phenol 
derivative 5 b that has been used successfully in the synthesis o f p-chiral phosphine 
oxides’79 was subsequently examined. Analogous reaction conditions afforded 6b with 
equally high selectivity. Again, raising the temperature did not adversely affect the 
selectivity. In contrast to 6a, 6b was readily obtained by recrystallization from EtOAc/ 
heptanes in diastereomerically pure form (>99.5:0.5 d.r) with an 5 configuration at the 
sulfur center as confirmed by a single-crystal X-ray structure.
Scheme 20. Screening for the synthesis o f compound 6
NH'
-Ts SO C b
OH Pyridine 




Table 7. Conditions surveyed for the synthesis o f 6
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E ntry 5 R 1 Base T f C ] 6 d .r
1 5a H Pyridine -40 6a 98:2
2 5a H Pyridine -15 6a 98:2
3 5a H Pyridine 0 6a 97:3
4 5b Cl Pyridine -40 6b 99:1
5 5b Cl Pyridine -1 0 6b 98:2
6 5b Cl Pyridine 0 6b 98:2
With sufficient quantities of the chiral template 6b in hand, the evaluation o f the 
synthesis o f (R)-tBSA (8a) by cleavage o f the S-N bond with terf-butylmagnesium 
chloride and subsequent cleavage o f the S-O bond upon addition of LHMDS was 
initiated (Table 8). Addition o f tBuMgCl to 6 in THF at -3 0  °C selectively cleaved the 
sulphur-nitrogen bond, thus providing the diastereomerically pure, stable, and crystalline 
sulfmate ester 7a in 91% yield. Then treatment o f 7a with LHMDS in THF at -1 0  °C to 
0°C  cleaved the sulphur-oxygen bond effectively in quantitative conversion. After 
quenching the reaction with aqueous NH4C1 solution, enantiopure (/?)-tBSA (8a) was 
isolated in 90%  yield and 99.7:0.3 e.r. Temperatures from -60 °C to -1 0  °C for the 
Grignard addition and 0 °C for the LHMDS addition did not result in any loss o f the 
enantiomeric purity o f 8a.
126
This efficient and simple method was further demonstrated in the synthesis o f other 
sterically hindered sulfinamides (Scheme 59, Table 8). A variety o f structurally diverse 
and sterically hindered alkyl and aryl sulfinamides were readily synthesized in high 
yields and e.r. values. In the case o f 8 d a n d 8 e, a slight decrease in enantiopurity was 
observed when the LHMDS addition was performed at higher temperature. An excellent 
e.r. value (99:1) was obtained if the addition was started at -7 8  °C or by addition o f 0.2 
equivalents o f MgBr2-OEt2. Additionally, it has been demonstrated that the double 
nucleophilic substitution can be carried out by a one-pot protocol. 180 But this method is 
not effective for the synthesis o f simple aryl sulfinamides, because after the sulfinate 
ester was obtained, it reacted immediately with aryl Grignards and mainly sulfoxide 
byproduct were obtained.
Scheme 21. Synthesis o f variety o f sulfinmides using new chiral auxiliary
T H F 
-7 8  °C  - 0  °C
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7a > 91 8a 89 99.7:0.3
7b O f 5* 85 8b 84 98.8:1.2
7c 75 8c 82 98.8:1.2
7d 8 8 8d 91 99:1
7e 6 8 8e 48 99.9:0.1
To highlight the utility o f this new process, the scope o f this chemistry was extended to 
the direct synthesis o f sterically hindered chiral sulfinyl ketimines (9a-e). Ketimines can 
be synthesized by addition o f an inline nucleophile to the sulfmate esters 7a-e (Table 8). 
Sulfinyl ketimines are key intermediates in the synthesis o f chiral amine compounds and 
their synthesis has been carried out by condensation of a ketone with sulfinamide in the 
presence o f a Lewis acid, such as tetra alkoxy titanium. However, when sterically 
hindered ketones are employed, the yield decreases even under forcing reaction
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conditions. Therefore, the synthesis of 9a-e from 7a-e would allow for an efficient and 
direct synthesis o f sterically hindered sulfinyl ketimines shown in scheme 22.
The synthesis of (5)-Ar-(tert-butyl-phenylmethylidene)-2-tert-butane-2-sulfinamide 9a 
was first explored. Addition o f tBuLi at -7 8  °C to benzonitrile in THF generated the 
lithium imide, which was then slowly added to 8a in THF at -7 8  °C. This hindered 
lithiumimide readily cleaves the sulphur-oxygen bond to yield sulfinyl ketimine 9a in 
good yield upon isolation and greater than 99:1 e.r., exclusively as one E/Z isomer (Table 
9). Increasing the reaction temperature led to decreased enantiopurity 90:10 e.r. for 9a at 
-4 0  °C. Conversely, under the same reaction conditions, the synthesis of 9a using the 
sulfmate 3 failed to provide the desired product and no reaction was observed in scheme 
19. This result clearly demonstrates the higher reactivity o f the sulphur-oxygen bond in 
the phenol backbone.
Scheme 22. Synthesis o f variety o f ketimines and amines
As presented in table 9, a variety o f hindered ketimines were prepared by following this 
sequence. Ketimines with different alkyl functionalities (9 a, c, d) were prepared in good 
yields and excellent selectivities. The ketamine 9e, containing a hindered aryl group, was 
also prepared in good yield and 98:2 e.r.
R' R'
i) PhC N , t-BuLi 
THF, -78  °C , 1h NaBH,N HTs
9 a-e 10 a -e
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Table 9. Synthesis o f sterically hindered chiral ketimines and amines
Compound R ’ Yield (%) er Compound Yield (%) dr
9a 85 99:1 10a 99 93:7
9c 91 99.5:0.5 10c 95 94:6
9d 78 98.3:1.6 lOd 98 95:5
9e 71 98.4:1.5 lOe 97 >99:1
For comparison, only 20 % yield was obtained from the condensation reaction between 
TIPP sulfinamide (TIPPSA) and the ketone. It is worth pointing out that ketimines with 
different sulfinyl groups would provide an avenue for fine-tuning the stereoselectivity in 
the synthesis o f chiral amines by either reduction or nucleophilic addition. While direct 
synthesis o f nonhindered chiral ketimines using Anderson’s reagent was previously 
reported, our newly developed chiral template allows an efficient and direct synthesis of 
structurally diverse bulky chiral sulfinyl ketimines by stereoselective substitution of a 
chiral sulfmate . 181' 183
The reduction o f 9 in the synthesis o f the chiral amine 10 was initially studied to under­
stand the effect o f the alkyl and arylsulfinyl groups on the stereoselectivity. Reduction
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of 9a with different reducing reagents was first examined. We have examined NaBH4, L- 
selectride, and 9-BBN, out of these three reducing agents NaBFLt in THF gave the best 
selectivity, thus providing 10a in 93:7 d.r. 184 and almost quantitative yield. The same 
reaction conditions were then applied to other substrates. Similar selectivities were 
observed when other alkylsulfinyl groups were used (10c, d). However, better selectivity 
was observed when the triisopropyl sulfinyl group was used, and only one diastereomer 
o f lOe was observed. The effect o f the sulfinyl group on the selectivity is obvious and the 
application o f this method in the synthesis o f other chiral amines under different reactions 
conditions is under further exploration.
For all these compounds the purity was tested by 'H  NMR, l3C NMR spectra and LC- 
MS. For few compounds spectra’s were shown in Figure 57, 58, 59, 60 and 61. Their 
chemical shift values were discussed in experimental section.
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*H NMR and 13C NMR spectra: 
Compound 7c:
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Figure 58. 'H  NMR (500 MHz, CDC13) and 13C NMR (125 MHz, CDC13) spectra for
compound 8c.
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C om pound 9c:
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Figure 60. 'H NMR (500 MHz. CDCh) and 13C NMR (125 MHz. CDCh) spectra for 
compound lOd.
C hiral HPLC of com pound 9c:
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Figure 61. Chiral HPLC condition: Chirapack AD-3 column, 4.6X250 mm, 10p; 25 % 
ethanol in heptane, 1.5 mL/min; 222nm; (R)-9c , rt = 3.14 min, (S)-9c, it = 2.33 min.
5.3. CONCLUSIONS
In summary, an efficient approach to enantioselective synthesis of diverse sulfinamides 
and imines using a new chiral auxiliary has been achieved. We have developed a chiral 
amine template based on a phenol backbone 5, from which the optically pure chiral 
sulfinyl-transfer agent benzo[l,3]oxathiozin-2-one 6  was prepared effectively. The 
intermediate 6  contains sulphur-nitrogen and sulphur-oxygen bonds with differentiated 
reactivities that allow the synthesis o f sterically hindered chiral sulfinamides and sulfinyl 
ketimines under mild reaction conditions. This method is practical, efficient, green, and 
has the potential to provide an economical commercial process for the synthesis of 
enantiopure bulky sulfinamides, such as tertiary butyl sulfinamide and triisopropyl 
sulfinamide.
5.4. EX PERIM EN TA L PRO CEDURE 
G eneral M ethods
All reactions were carried out under argon atmosphere, reagents and solvents were 
obtained from commercial suppliers used directly without any purifications. All the 
solvents were used for the reaction were purchased from sigma-aldrich. All reactions, 
unless otherwise noted were carried out in oven dried glassware under argon atmosphere. 
Combiflash chromatography was carried out using silicycle 230-400 mesh silcagel. Thin- 
layer chromatography (TLC) analysis was performed with Merck Kieselgel 60 F 254
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plates, and visualized using UV light and phosphomolybdic (PMA) staining. LC-MSD 
was carried on Agilent 1100 series. ]H NMR and proton-decoupled 13C NMR spectra 
were obtained with Bruker 400 or 500MHz spectrometers in CDCI3 with TMS as an 
internal standard. Proton and carbon spectra chemical shifts were reported using TMS 
and CDCI3 as internal standard at 0 ppm and at 77.23 ppm, respectively. Diastereomeric 
ratios were determined by *H NMR spectrum analysis as well as HPLC analysis. 
Enantiomeric excess were obtained by chiral HPLC analysis using Chiral pack AS, AD 
and OD ChiralCel columns.
Synthesis of (2S, 4/f)-6-chIoro-4-methyl-3-[(4-methylphenyI)sulfonyl]-3,4-dihydro- 
l,2,3-benzoxathiazine2-oxide (6b)
A 3-neck 250 ml round-bottom flask fitted with a stiring bar, and argon inlet, was 
charged with amine (20 g, 61.2 mmol) and THF (120 ml) cooled to -30 °C . To this 
solution thionyl chloride (6.08 ml, 85.6 mmol) was added drop wise, followed by 
pyridine (12 ml, 0.153 mol) was added dropwise over 30 min. Reaction was monitored 
through TLC and LC-MS. Reaction was completed after lhr, quenched the reaction 
mixture with saturated sodium bicarbonate and diluted with ethylacetate. The organic 
layer was washed with brine and dried over Na2SC>4 . The organic phase was condensed 
under a rotavap and the residue was recrystallized using EtOAC/Hexane. The product 
was obtained as white crystalline solid with (18.67 g) 82% yield and 99.6:0.4 dr. 'H  
NMR (400 MHz, CDC13): 5 1.75 (d, J  = 7.2 Hz, 3H), 2.39 (s, 3H), 4.86 (q, J =1.1 Hz, 
1H), 6 .8 8  (d, J = 8.7 Hz, 1H ), 7.02 (d, J = 2.2 Hz, 1H), 7.16 (dd, J = 8.7 Hz, 1H), 7.25 
(d, J = 8.0 Hz, 2H ), 7.69 (d, J = 8.3 Hz, 2H). 13C NMR (100 MHz, CDC13): 5 21.6, 23.9,
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51.9, 121.4, 126.1, 127.1, 127.3, 129.2, 130.1, 130.1, 135.1, 142.8, 143.3. HRMS: m/z 
calculated for C i5H 14C1N0 4 S2 Na (M+Na); 393.9950; found: 393.9952.
Synthesis o f 4-chloro-2-((R)-l-(4-methylphenylsulfonamido)ethyl)phenyl 2- 
methylpropane-2-sulfinate (7a):
A 3-neck, 250 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with compound (6) (5 g, 13.47 mmol,
1.0 equiv) and THF (15 mL). The reaction mixture was cooled to an internal temperature 
o f -30 °C by using dry ice and water mixture To this solution t-BuMgCl (2 M in THF, 
7.4 mL, 14.7 mmol, l.lequiv) was added dropwise over 15 min. The reaction mixture 
was maintained at an internal temperature between -30 °C to -20 °C, with monitoring by 
TLC and LC-MS. After lh  the reaction was quenched with saturated N aH C 03 (15 mL) 
at this temperature, temperature was raised when adding the base and diluted with EtOAc 
and the layers were separated. The aqueous fraction was back-extracted with EtOAc (2 x 
50 mL) and the layers were separated. The combined organic fractions were washed with 
brine and dried over Na2S0 4 . The organic fraction was concentrated under reduced 
pressure. Purification by column chromatography (30% EtOAc:hexanes) provided the 
desired product as a white solid (5.26 g, 91 %). 'H  NM R (500 MHz, CDC13) 5 7.56 (d, 7 
= 8.2 Hz, 2H), 7.07 (d, 7 = 8.2 Hz, 2H), 7.03 (dd, 71=72=8.7 Hz, 1H), 6.89 (d, 7 = 8.7 Hz, 
1H), 6.71 (d, 7 = 2 .7  Hz, 1H), 5.76 (d, 7 = 8.9 Hz, 1H), 4.51 (q, 7 = 7.2 Hz, 1H), 2.33 (s, 
3H), 1.46 (d, 7 = 7.2 Hz, 3H), 1.39 (s, 9H); 13C (125 MHz, CDC13) 6 21.4, 21.8, 22.8, 
50.8, 59.1, 122.0, 127.1, 128.4, 129.1, 129.1, 130.6, 135.6, 137.5, 143.0, 149.9. HRMS: 
m/z calculated for C 19H25CINO4S2 (M+H), 430.0914; found: 430.0908.
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Synthesis of 4-chloro-2-((R)-l-(4-methylphenylsulfonamido)ethyl)phenyl 2- 
methylbutane-2-sulfinate (7b)
A 3-neck 50 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with compound (6) (3 g, 8.06 mmol) 
and THF (10 mL). The reaction mixture was cooled to an internal temperature o f -30 °C. 
To this solution 1,1-dimethyl propyl magnesium chloride solution (1M, 10.5 mL, 10.47 
mmol, 1.3 equiv) was added drop wise for 15 min. The reaction mixture was maintained 
at an internal temperature between -30 °C to -20 °C, with monitoring by TLC and LC- 
MS. Reaction was completed after 45 min, quenched with saturated NaHCC>3 (15 mL) 
and the organic layer extracted with EtOAc (30 mL). The organic layer was washed 
with brine and dried over Na2S0 4 . The organic phase was allowed to dryness, and the 
residue was crystallized from EtOAc/hexanes. The product (7b) was obtained as white 
solid (2.98 g, 85.14 %). 'H  NMR (500 MHz, CDC13) 5 7.57 (d, J = 8.4 Hz, 2H), 7.08 (d, 
7 = 8.0 Hz, 2H), 7.05 (dd, 71 =72= 8.4 Hz, 1H ), 6.89 (d, J=  8.7 Hz, 1H), 6.70 (d, 7 = 2.3 
Hz, 1H), 5.78 (d, 7 = 8.9 Hz, 1H ), 4.49 (m, 1H), 2.32 (s, 3H), 1.83 (m, 1H), 1.75 (m, 
1H), 1.47 (d, 7 = 7.5 Hz, 3H), 1.36 (s, 3H), 1.346 (s, 3H), 1.07 (t, 7 = 7.6 Hz, 3H); ,3C 
(125 MHz , CDClj) 5 7.8, 18.46, 18.48, 21.4, 22.8, 27.7, 50.9, 62.6, 122.0, 127.1, 128.4,
129.12, 129.18, 130.5, 135.6, 137.5, 143.0, 150.0. HRMS: m/z calculated for 
C2oH27C1N04S2 (M+H), 444.1067; found: 444.1064.
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Synthesis of 4-chloro-2-((R)-l-(4-methylphenylsulfonamido)ethyl)phenyI 3- 
ethylpentane-3-sulfinate(7c)
A 3-neck 50 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with compound (6 ) (lg , 2 .6 8  mmol) 
and THF (6  mL). The reaction mixture was cooled to an internal temperature o f -45 °C. 
To this solution 1,1,1-triethylmethylmagnesiumchloride solution (0.15 M, 19.6 mL, 2.94 
mmol, 1.1 equiv) was added drop wise for 15 min. The reaction mixture was maintained 
at an internal temperature between -45 °C to -30 °C, with monitoring the reaction using 
TLC and LC-MS. Reaction was completed after lh, quenched with saturated sodium 
bicarbonate (10ml) and the organic layer extracted with EtOAc (2 x 15mL). The organic 
layer was washed with brine and dried over Na2S0 4  . The organic fraction was 
concentrated under reduced pressure. Purification by column chromatography (30% 
EtOAc:hexanes) provided the desired product as a white solid (0.94 g,75 %). 'H  NMR 
(500 MHz , CDC13) 5 7.57 (d, J = 8.1 Hz, 2H), 7.08 (d, J  = 7.9 Hz, 2H), 7.05 (dd, 7, = J2 
= 8.4 Hz, 1H ), 6.89 (d, J = 8.4 Hz, 1H), 6.78 (d, J = 2.2 Hz, 1H), 5.96 (d, J = 8 .8  Hz, 1H 
), 4.52 (m, 1H), 2.33 (s, 3H), 1.825(m, 6 H), 1.44 (d, J  = 7.0 Hz, 3H), 1.06 (t, J = 7.4 Hz, 
9H).13C (125 MHz, CDCI3) 5 8.1, 22.9, 23.5, 50.3, 67.9, 121.8, 127.0, 128.3, 128.7, 
129.2, 130.4, 135.7, 137.4, 143.0, 150.0. HRMS: m/z calculated for C22H3 iC1N0 4S2 
(M+H), 472.1383; found: 472.1381.
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Synthesis of 4-chloro-2-((R)-l-(4-methylphenyIsulfonamido)ethyl)phenyI 1- 
methylcyclohexane-1 -sulflnate (7d)
To a solution o f 6  (8.5 g, 22.9 mmol) in THF (60 mL) cooled to -15 °C , to this solution 
added 1-methylcyclohexylmagnesium chloride (78 mL, 0.32 M in THF, 24.9 mmol) 
slowly while keeping the reaction temperature <-12 °C. After addition, the mixture was 
stirred for 30 min to complete the reaction as monitored by TLC and LC-MS analysis. 
Saturated aqueous NH4CI solution (50 mL) was added to quench the reaction and diluted 
with brine (40 mL) and EtOAc (100 mL). The mixture was warmed to RT and the 
organic phase was removed. The aqueous phase was extracted once with EtOAc (50 mL). 
The combined organic phases were dried over Na2S0 4  and concentrated. The residue was 
purified by chromatography eluted with EtOAc/hexane (5:95 to 20:80, v/v) to yield 7d 
(10 g) as a white solid in 90 % yield. 1H NMR (500 MHz, CDCb) 8 , 1.43 (s, 3H), 1.46 
(d, J = 7.5 Hz, 3H), 1.51-1.87 (m, 10H), 4.45(m, 1H), 2.33 (s, 3H), 5.84 (d, J = 9.0 Hz , 
1H), 6.70 (d, J = 2.6 Hz, 1H); 6.87 (d, J  = 8 .6  Hz, 1H),7.03 (dd, J1 =J2 = 2.60, 8.4 Hz, 
1H ), 7.08 (d, J  = 7.9Hz, 2H), 7.57 (d, J = 8.3Hz, 2H), ,3C (125 MHz,CDCB) 5 15.2,
21.3, 21.4, 21.5, 22.8, 25.4, 29.7, 30.8, 50.4, 62.7, 122.0, 127.1, 128.3, 128.8, 129.2,
130.4, 135.7, 137.4, 143.0, 149.9. HRMS: m/z calculated for C22H29CINO4S2 (M+H), 
470.1227; found: 470.1227.
Synthesis of 4-chIoro-2-((R)-l-(4-methylphenylsulfonamido)ethyI)phenyl 2,4,6- 
triisopropylbenzenesulfinate (7e)
A 3-neck 50 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with compound (6) (3 g, 8.08 mmol)
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and THF (12 mL). The reaction mixture wascooled to an internal temperature of -78 °C. 
To this solution 1,3,5-triisolpropylphenylmagnesium bromide solution (0.23 M, 35.5 mL,
8.8 mmol, 1.1 equiv) was added drop wise for 30 min. Reaction was monitored using 
TLC and LC-MS, completed after lh. Reaction was quenched with sat’d N aH C 03 
sodium bicarbonate (15 mL) and the organic layer extracted with EtOAc (2 x 25 mL). 
The organic layer was washed with brine and dried over Na2S04. The organic fraction 
was concentrated under reduced pressure. Purification by column chromatography (30% 
EtOAc:hexanes) provided the desired product as a white solid (3.16g, 68 %). lH NMR 
(500 MHz ,CDC13) 5 7.46 (d, J = 8.4 Hz, 2H ), 7.18 (s, 2H), 7.09 (d, J  = 8.4 Hz, 2H),
7.08 (d, J = 2.0 Hz, 1H), 7.04 (d, J = 7.8 Hz, 1H), 6.83 ( br, s, 1H), 5.38 (br, 1H), 4.58 
(m, 1H), 4.01 (sep, J  = 7.2 Hz, 2H), 2.90 (sep, J= 12  Hz, 1H), 2.33 (s, 3H), 1.35 (d, J =
6.8 Hz, 3H), 1.32 (d, J = 6.8 Hz, 12H), 1.28 (d, J = 6.8 Hz, 6H); l3C NMR (125 MHz, 
CDCh) 6 21.4, 22.9, 23.6, 23.7, 24.3, 24.5, 28.5, 31.5, 34.5, 49.9, 121.3, 123.2,126.9,
128.3, 128.3, 129.2, 130.3, 135.2, 135.2, 137.1, 137.3, 143.1, 149.3, 150.5, 154.3. 
HRMS: m/z calculated for C30H39CINO4S2 (M+H), 576.2009; found: 576.2004.
Synthesis of (R)-tcrt-butanesulfmamide (8a).
A 3-neck 50 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with compound (7a) (3 g, 6.9 mmol) 
dissolved in THF (10 mL) at 0 °C. To this solution LiHMDS solution (1 M, 5.3 mL, 2.2 
equiv) added at 0 °C. Reaction was monitored using TLC and LC-MS, completed after 
lh. Reaction was quenched with water (3 mL) and the organic layer was extracted with 
EtOAc (2 x 25 mL) and dried over Na2S04, The organic fraction was concentrated under
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reduced pressure. Purification by column chromatography (90% EtOAC: hexanes) 
provided the desired auxiliary (2.43 g, 94%) and (R)-tert-butanesulfinamide (0.75 g, 89 
%) with 99.38 % ee. The enantiomeric excess was analyzed by chiral HPLC analysis.
!H NMR (500 MHz, CDC13) 8 3.82 (br, 2H), 1.18 (s, 9 H )n C NMR (125 MHz, CDC13) 5 
22.1, 55.3. Chiral HPLC condition: Chiralpak AS column, 4.6X250 mm, lOp; 90:10 
hexane ethanol; l.Oml/min; 222nm; (R ) , rt-  6.6min, (S), rt = 9.4min.
Synthesis of (R)-2-methyl butane-2-suifinamide (8b)
A 3-neck 100 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with compound (7b) (3 g, 6.7 mmol) 
and dissolved in THF (12 mL) at -5 °C to 0 °C. To this solution LiHMDS solution (1M,
14.8 mL, 2.2 equiv) was added at 0 °C. The reaction mixture was maintained at an 
internal temperature 0 °C, with monitoring by TLC and LC-MS. Reaction was completed 
after lh, quenched with water (3 mL) and the organic layer was extracted with EtOAc 
(50 mL) and dried over Na2S 0 4. The organic fraction was concentrated under reduced 
pressure. Purification by column chromatography (90% EtOAC: hexanes) provided the 
desired product (R )-1,1-dimethyl propylsulfinamide (0.76g, 84 %) with 99.7% ee. The 
enantiomeric excess was analyzed by chiral HPLC analysis. 5H NMR (500 MHz, CDC13) 
8 8 0.98 (t, 7 = 7.4 Hz, 3H), 1.16 (d, 7 = 6.2, 6H), 1.65( ds, 7 =  4.6 Hz, 7.5 Hz, 2H), 4.2(b, 
2H).I3C NMR (125 MHz, CDC13) 8 7.9, 18.5, 18.63, 28.5, 58.7. Chiral HPLC condition: 
ChiralCelAD-H column, 4.6X250 mm, lOp; 20% ethanol in heptane; 1.2ml/min; 222nm; 
(R ) , rt= 9.88 min, (S), rt = 13.41 min.
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Synthesis of (R)-2-methyl butane-2-sulfinamide (8c)
A 3-neck 50 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with compound (7c) (200 g, 0.423 
mmol) and THF (3 mL) at -35 °C. To this solution LiHMDS solution (1M, 1.27 mL, 1.26 
mmol, 3 equiv) was added at this temperature, reaction moved slolwly to 0 °C . Reaction 
was monitored using TLC and LC-MS, to push the reaction added another 1 equiv of 
LIHMDS. The reaction mixture was maintained at an internal temperature 0 °C, with 
monitoring by TLC and LC-MS. Reaction was completed after 5h, quenched with water 
(3 mL) and extracted with ethyl acetate and dried over Na2S0 4 . The organic fraction was 
concentrated under reduced pressure. Purification by column chromatography (90% 
EtOAC: hexanes) provided the desired product (R)-l,l,l-trim ethylpropylsulfinamide 
(50.5 mg, 73 %) as a white solid with >99:1 er. The enatiomeric ratio was analyzed by 
chiral HPLC analysis. !H NMR (500 MHz, CDC13) 5 3.75 (s, 2H), 1.62-1.77 (m, 6H), 
0.98 ( t, J  = 6.8 Hz, 9H).13C NMR (125 MHz, CDC13) 6 8.2, 23.6, 63.6. Chiral HPLC 
condition: Chiralcel OD column, 4.6X250 mm, lOp; isopropanol in heptanes (15:85. v/v), 
35 °C, l.Oml/min; 222nm;(/?)-8c , rt = 8.10 min, (S)-8c, rt = 11.10 min.
Synthesis of (R)- 1-methylcyclohexane-l-sulfinamide (8d)
A 3-neck 50 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with amine (7d) (200 mg, 0.42 mmol) 
and THF (3 mL). The reaction mixture was cooled to an internal temperature o f 0 °C. To 
this solution magnesium bromide diethyl etherate (54.94 mg, 0.21 mmol) was added and 
cooled down to -40 °C , at this temperature LiHMDS solution (1M, 1.05 mL, 2.5 equiv)
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was added slowly. To push the reaction added another 1.5equiv o f LiHMDS and moved 
slowly to 0 °C , reaction was completed after 4h. Reaction was quenched with water (3 
mL) and extracted with ethyl acetate(10 mL) and dried over Na2S04 . The organic 
fraction was concentrated under reduced pressure. Purification by column 
chromatography (90% EtOAC: hexanes) provided the desired product (R)- 1- 
methylcyclohexane-1-sulfinamide (61.25 mg, 90 %) as whiter solid with 98.92:1.07 er. 
The enantiomeric ratio was analyzed by chiral HPLC analysis. 'H  NMR (500 MHz, 
CDCb): 6 3.67 (s, 2H), 1.27-1.79 (m, 10H), 1.19 (s, 3 H )UC NMR (125 MHz, CDC13) 
5 14.9, 21.5, 21.7, 25.5, 30.2, 32.1, 58.8. HRMS: m/z calculated for C7H ,6NOS (M+H): 
162.0953; found: 162.0943. Chiral HPLC condition: ChiralCelAD-H column, 4.6X250 
mm, lOp; heptane/IPA :7:3; l.Oml/min; 222nm; (R ) , r,=  3.62 min, (S), r, = 4.41 min.
Synthesis of (R)-2,4,6-triisopropylbenzenesulfinamide (8e).
A 3-neck 50 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with (7e) (1 g, 2.69 mmol) and THF 
(6 mL), the solution was kept at -78 °C. To this solution 1,3,5-Triisopropyl phenyl 
magnesium bromide solution (0.20 M , 10.38 mL, 3.23 mmol, 1.2 equiv) was added drop 
wise over 30 min. Reaction was monitored using TLC and LC-MS, observed some 
double addition product. After 2h, added the LiHMDS (1M, 8.07 mL, 8.07 mmol, 
3equiv) solution drop wise over 15 min .The completion o f the reaction took for the two 
steps in 3:30 h. Reaction was quenched with saturated sodium bicarbonate (15 mL) and 
the organic layer was extracted with EtOAc(2 x 20 mL), organic layer was washed with 
brine and dried over Na2S04 .The organic fraction was concentrated under reduced
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pressure. Purification by column chromatography (50% EtOAC: Hexane) provided the 
desired product (R) 1,3,5-Triisopropylphenylsulfmamide (0.34 g, 48 % ) as white solid 
with 99.49 % ee. ‘H NMR (500 MHz, CDC13) 8 7.08 (s, 2H), 4.45 (s, 2H), 4.00 (sep, J =
7.0 Hz, 2H), 2.84 (sep, J = 7.0 Hz, 1H), 1.32 (d, J  = 7.0 Hz, 6H), 1.27 (d, J = 6.7 Hz, 
6H), 1.23 (d, J = 7.0 Hz, 6H); 13C NMR (125 MHz, CDC13) 5 23.7, 24.1, 24.3, 28.2,
34.3, 123.0, 138.7, 147.3, 151.9. Anal.Calcd. for C |5H25NOS : C, 67.37; H, 9.42; N, 5. 
24; O, 5.98; S, 11.99. Chiral HPLC condition: Chiralcel OD-H column, 4.6X250 mm, 
lOp; 90:10: Isopropanol/hexane; l.Oml/min; 222nm; (R ) , rt= 4.18min, (S), rt = 5.03 min.
Synthesis of (R,E)-N-(2,2-dimethyl-l-phenyIpropylidene)-2-methylpropane-2- 
sulfinamide(9a)
A 3-neck 50 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with compound (7a) (1 g, 2.32 
mmol) and THF (6 mL). The solution was kept at -78 °C. In another flask, charged with 
benzonitrile (0.73 mL, 7.16 mmol) and THF (2.5 mL) cooled down to -78 °C. To this 
solution t-Butyllithium (1.7 M, 6.96 mL, 6.96 mmol) was added drop wise over 30 min. 
The solution was turned in to light orange red colour , after lh  this solution was added to 
solution o f (7a) . Reaction was monitored using TLC and LC-MS, completed after lh, 
quenched with 2M NaOH..The organic layer was extracted with hexane (2 x 20 mL), 
organic layer was washed with brine and dried over Na2S 0 4 . The organic fraction was 
concentrated under reduced pressure. Purification by column chromatography (30 % 
EtOAc: Hexane) provided the desired product (9a) (0.52 g, 85 %) as a white solid with 
>99 :1 er. lH NMR (500 MHz, CDC13) 5 7.34 (m, 3H), 7.07 (m, 2H), 1.22 (s, 9H), 1.19
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(s, 9H). 13C NMR (125 MHz, CDC13) 8  22.0, 28.0,42.6, 55.8, 126.5, 127.7, 128.3, 137.0,
192.5. HRMD: m/z calculated for C i5H24NOS (M+H), 266.1579; found, 266.1573. Chiral 
HPLC condition: ChiralCel AD-H column, 4.6X250 mm, lOp; 1.0 % isopropanol in 
heptane,l.Oml/min; 222nm; (S)-9a , rt = 2.78 min; (R)-9a, rt = 4.58min.
Synthesis of (R,E)-N-(2,2-dimethyl-1 -phenylpropylidene)-3-ethylpentane-3- 
sulfinamide (9c)
A 3-neck 50 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with compound (7c) (200 mg, 0.42 
mmol) and THF (3 mL) , the solution was kept at -78 °C. In another flask was charged 
with benzonitrile (0.18 mL, 1.76 mmol) and THF (2.5 mL) cooled down to -78 °C. To 
this solution t-Butyllithium (1.7M, 0.98 mL, 1.6 8  mmol) was added drop wise over 30 
min. The solution was turned in to light orange red colour , after lh  this solution was 
added to solution o f (7c) . Reaction was monitored using TLC and LC-MS, completed 
after lh, quenched with 2M NaOH .The organic layer was extracted with hexane (2 x 
20 mL), organic layer was washed with brine and dried over Na2S 0 4 . The organic 
fraction was concentrated under reduced pressure. Purification by column 
chromatography (30 % EtOAc: hexanes) provided the desired product (9c) (119 mg, 91 
%) as a white solid with >99 :1 er. ]H NMR (500 MHz, CDC13) 5 7.32 (m, 3H), 7.0 (m, 
2H), 1.66 (m, 6 H), 1.21 (s, 9H), 0.93 (t, J = 7.4 Hz, 9H); l3C NMR (125 MHz, CDC13) 8
8.3, 23.7, 28.1, 42.7, 64.8, 127.6, 128.2, 137.0, 191.3. HRMS: m/z calculated for 
C 18H30NOS (M+H), 308.2048; found:308.2044. Chiral HPLC condition: Chirapack AD-3
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column, 4.6X250 mm, lOju; 25 % ethanol in heptane, 1.5 mL/min; 222nm; (R)-9c , rt = 
3.14 min, (S)-9c, rt = 2.33 min.
Synthesis of (R,E)-N-(2,2-dimethyl-l-phenylpropylidene)-l-methylcyclohexane-l- 
sulfinamide (9d)
A 3-neck 50 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with compound (7d) (500 mg, 1.06 
mmol) and THF (3 mL) , the solution was kept at -78 °C. In another flask was charged 
with benzonitrile (0.45 mL, 4.45 mmol) and THF (3 mL) and cooled down to -78 °C. To 
this solution t-Butyllithium (1.7 M, 2.4 mL, 4.24 mmol) was added drop wise over 30 
min. The solution was turned in to light orange red colour , after lh  this solution was 
added to solution o f (7d). Reaction was monitored using TLC and LC-MS, completed 
after lh , quenched with 2M NaOH. The organic layer was extracted with hexane (2 x 
15 mL), organic layer was washed with brine and dried over Na2S0 4  . The organic 
fraction was concentrated under reduced pressure. Purification by column 
chromatography (30% EtOAc: Hexane) to afford the desired product (9d) (0.25 g, 78 %) 
as a white solid with >98:2 er. 'H  NMR (500 MHz, CDCI3) 5 1.22 (s, 9H), 1.24 (s, 3H), 
1.35-1.72 (m, 10H), 7.0 (m, 2H) ,7.32(m, 3H); 13C NMR (125 MHz, CDC13) 6  15.7,
21.5, 21.7, 25.7, 28.1, 30.1, 31.1, 42.6, 59.6, 126.5, 127.7, 128.2, 137.1; HRMS: m/z 
calculated for C ,8H28NOS (M+H), 306.1892; found: 306.1885. Chiral HPLC condition: 
ChiralCel OJ-3 column, 4.6X250 mm, lOp; 6 % isopropanol in heptane, l.Oml/min; 
222nm; (R)-9d , rt = 4.42 min, (S)-9d, rt = 3.62 min.
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Synthesis of (R,E)-N-(2,2-dimethyl-l-phenylpropylidene)-2,4,6-triisopropyIbenzene 
sulfinamide.
A 3-neck 50 ml round-bottom flask fitted with a magnetic stirring bar, an internal 
temperature probe, and an argon inlet was charged with benzonitrile(0.16 mL, 1.56 
mmol) and THF (2.5 mL) and cooled down to -78 °C. To this solution t-Butyllithium 
(1.7 M, 0.87 mL, 1.48 mmol) was added drop wise over 30 min. The solution was turned 
in to light orange red colour . In another flask compound (7e) (200 mg, 0.37 mmol) was 
dissolved in THF (3 mL) and the solution was kept at -78 °C.This solution was added to 
the imine dropwise over few minutes. Reaction was monitored using TLC and LC-MS, 
completed after lh , quenched with 2M NaOH. The organic layer was extracted with 
hexane (2 x 20 mL), organic layer was washed with brine and dried over Na2S0 4 . The 
organic fraction was concentrated under reduced pressure. Purification by column 
chromatography (30 % EtOAc: Hexane) to afford the desired product (9e) (95 mg, 64 %) 
as a white solid with 98.5:1.5 er. 'H  NMR (500 MHz, CDC13) 5 1.12 (d, J =6.5 Hz, 6H), 
1.17 (d, J =6.8 Hz, 6H), 1.19 (s, 9H), 1.23 (d, J = 6.9 Hz, 6H), 2.86 (hept, J=6.90 Hz, 
1H), 3.10-4.0 (b, 2H), 6.70-7.0 (m, 4H), 7.27-7.40(m, 3H). 13C NMR( 125 MHz, CDC13) 
6 23.65, 23.71, 25.17, 27.88, 28.36, 34.28, 42.15, 122.38, 126.06, 127.92, 128.29, 137.12,
138.13, 149.99, 152.48, 187.73; HRMS: calculate for C26H38NOS (M+H), 412.2674; 
found: 412.2674. Chiral HPLC condition: Chiralcel OD-H column, 4.6X250 mm, lOp; 1 
% EtOH in heptane, 1.0 ml/min; 222nm; (R)-9e , rt = 5.06 min, (S)-9e, rt = 4.67min.
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General procedure for reduction of Imine:
Synthesis of (R)-N-((S)-2,2-dimethyl-l-phenylpropyl)-2-methylpropane-2- 
suifinamide (10a)
In a vial compound (9a) (50 mg, 0.18 mmol) was dissolved in anhydrous THF (1 mL). 
This solution was kept at -50 °C, at this temperature sodium borohydride (21.38 mg, 0.56 
mmol) was added after 30 min. Reaction was slowly moved to room temperature. 
Reaction went 100% completion after 90 min. Reaction was quenched with water (lm L) 
and extracted with EtOAc (10 mL). The crude product was concentrated to get the 
desired product with (48.3 mg, 98 %) with 93:7 dr. 'H  NMR (500 MHz, CDCI3) 8  7.24 
(m, 5H), 4.12 (br, 1H), 3.57(m, 1H), 1.22 (s, 9H), 0.94 (s, 9H).,3C NMR (125 MHz, 
CDCI3) 8  22.6, 26.7, 35.2, 55.5, 67.1, 127.4, 127.5, 129.5, 139.1. HRMS: m/z calculated 
for C 15H26NOS (M+H), 268.1735; found: 268.1735.
Synthesis of (R)-N-((S)-2,2-dimethyI-l-phenylpropyl)-3-ethylpentane-3-sulfinamide 
(10c)
In a vial compound (9c) (50 mg, 0.162 mmol) was dissolved in anhydrous THF (1 mL). 
This solution was kept at -50 °C, at this temperature sodium borohydride (18.4 mg, 0.487 
mmol) was added after 30 min reaction was slowly moved to room temperature. Reaction 
went 100% completion after 90 min. The reaction was quenched with water (1 mL) and 
extracted with EtOAc (10 mL). The crude product was concentrated to get the desired 
product with (47.5 mg ,95 % ) with 94:6 dr. 'H  NMR (CDCI3, 400 MHz) 8  0.90-0.98 (m, 
17H), 1.61-1.74 (m, 7H), 3.81 (s, 1H), 4.14 (d, J = 2.2 Hz, 1H), 7.22-7.29 (m, 5H); ,3C
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(CDCh, 100 MHz): 8 8.4, 24.1, 27.0, 35.4, 64.3, 67.7, 127.5, 127.6, 129.7, 139.4. HRMS: 
m/z calculated for C 18H32NOS (M+H), 310.2205; found: 310.2202.
Synthesis of (R)-N-((S)-2,2-dimethyl-l-phenylpropyl)-l-methylcyclohexane-l- 
sulfinamide (lOd)
In a vial compound (9d) (50 mg, 0.18 mmol) was dissolved in anhydrous THF (1 mL). 
This solution was kept at -50 °C, at this temperature sodium borohydride (21.38 mg, 0.56 
mmol) was added after 30 min reaction was slowly moved to romm temperature. 
Reaction went 100% completion after 90 min. The reaction was quenched with water (1 
mL) and extracted with ethylacetate. The crude product was concentrated to get the 
desired product with (49.5 mg, 98 %) with 95:5 dr. ’H NMR (500 MHz, CDCI3) 8 0.94 
(s, 9H), 1.22 (s, 9H), 1.2-1.77 (m, 10H), 4.15 (br, 1H), 3.60 (m, 1H), 7.24 (m, 5H). I3C 
NMR (125 MHz, CDCI3) 8 15.5, 21.48, 21.7, 25.5, 26.8, 30.7, 32.6, 35.2, 59.1, 67.0,
127.4, 127.5, 129.5. HRMS: m/z calculated for C i8H30NOS (M+H), 308.2048; found: 
308.2045.
Synthesis of (R)-N-((S)-2,2-dimethyl-l-phenylpropyl)-2,4,6-triisopropyI benzene 
sulfinamide (lOe)
In a vial compound (9e) (50 mg, 0.18 mmol) was dissolved in anhydrous THF(1 mL). 
This solution was kept at -50 °C, at this temperature sodium borohydride (21.38 mg, 0.56 
mmol) was added after 30 min. Reaction was slowly moved to room temperature. 
Reaction went 100% completion after 90 min. The reaction was quenched with water 
(lm L) and extracted with EtOAc (10 mL) The crude product was concentrated to get the 
desired product with ( 49mg, 97 %) with >98:2 dr. ‘H NMR (500 MHz, CDCI3) 8 0.95
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(s, 9H), 1.18-1.28(m, 18H), 2.82-2.90 (m, 1H), 3.72-4.10 (b, 2H), 4.30 (d, J  = 2.0 Hz, 
1H), 4.75-4.79 (m, 1H), 7.24-7.37(m, 5H).I3C NMR (125 MHz, CDC13) 5 23.7, 23.7,
24.3, 24.3, 26.7, 28.1, 30.3, 34.2, 34.8, 67.2, 122.9, 127.5, 127.6, 129.6, 137.9, 138.7, 




In summary, we have synthesized and studied several new series o f low molecular weight 
gelators (LMWGs) from D-glucose and D-glucosamine as the starting materials. D- 
glucosamine is a versatile starting material to make different peptoids and triazoles which 
were discussed in chapters 2, 3 and 4. We have also synthesized a new class o f  chiral 
oxathiozinone and hindered amines from chiral amino phenol as discussed in chapter 5.
From the research results in chapters 2, 3, and 4, we can draw some conclusions 
regarding the design, synthesis, and properties o f  several series o f  gelators from simple 
carbohydrate based starting materials. Figure 62 shows the several sugar headgroups (1- 
3) used in this study. A series o f  amides, ureas were prepared using compound lb . The 
triazoles o f  compound 2 and 3 have been compared in self-assembly study. These 
compounds form stable hydrogels and organogels. The role o f triazole and different 
functional groups in affecting the self-assembly properties was studied. The following are 
detailed summaries for each o f these systems.
N H A c A cO( la )  R1 = Me 
( lb )  R1 = CH2Ph 2 3
Figure 62. Principal structures o f sugar headgroups used for gelation studies.
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In chapter 2, we have designed and synthesized a series o f  low molecular weight 
tripeptoids by a one-pot Ugi reaction and obtained several effective 
organo/hydrogelators. These compounds are brand new class o f  organogelators that have 
not been reported before. Using MCRs to discover low molecular weight gelators is a 
novel method that will produce interesting structures with a variety o f  potential 
applications. The compounds 4, 5, 6 and 7 formed gels in ethanol, DMSO and water 
mixtures. Compounds 4, 7 formed in part due to the presence o f  glycine ester and 
bromine atom on phenyl group. In case o f compound 5 there is no bromine, and the 
gelation behaviour o f this compound is not as great compared to 6. From this we 
conclude that not only hydrogen bonding affects gelation but also the electronic effect 
plays a very important role in these kind o f  molecules.126*’185
OM e
Br
Figure 63. The structures o f peptoid derivatives which are effective LMWGs.
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Among the different triazole derivatives studied here, the long aliphatic chain 
derivatives showed the best gelation results. Several o f  these compounds are shown in 
Figure 63, the saturated alcohol derivatives 8-10, one acid derivative 11 and alkyl 
derivatives o f  12-14. Compounds 10, 12 and 14 form gels in pure water and aqueous 









Figure 64. Several different sugar triazole from compound 2.
After synthesizing the N-acetyl glucosamine derivatives we have chosen the D-glucose 
for our studies. When compared to compounds 8-14 the compounds 15-21 are not giving
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better result. Only compound 18 formed hydrogel and interestingly the dimer o f D- 
glucose triazole formed gels than the N-acetate system. In general the longer chain alkyl 
derivatives formed more stable gels at lower concentrations. Further studies using IR, 
small angle x-ray scattering or x-ray powder diffraction will be done in the future to help 
















Figure 65. Several different sugar triazole from compound 3.
The third type o f  gelators synthesized contains the apha-benzyl substituent at the 
anomeric position. Among the amide and urea derivatives o f  compound lb  that were
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synthesized, several o f them showed positive gelation results in either DMSO, ethanol, 
water or mixtures o f  water and DMSO or ethanol. The structures o f these compounds are 
shown in Figure 65. The terminal alkyl derivatives were the more efficient gelators. For 
the short chain alkyl amides and ureas, we found that 6-7 carbon chain ureas gave the 
best gelation results.
Figure 66. Amide and urea derivatives o f  compound lb .
These results indicated that besides hydrogen bonding, many other non-covalent forces 
are important in the self-assembly o f these compounds. These include van der Waals 
interactions. The essential requirement is that that the molecules can self-assemble into 
entangled network therefore entrapping the solvent. The rheology o f these analogs 
indicates that G' and G" values for ureas were more than the amide. From this we can 
predict that hydrogen bonding plays an important role in case o f  both amides and ureas , 
but ureas can form stronger hydrogen bonding than am ides.188
22 23 24 25
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In chapters 5, we report a new chiral sulfinyl-transfer agent containing a more activated 
S -0  bond, from which both sterically hindered enantiopure sulfinamides and sulfinyl 
ketimines were prepared under mild reaction conditions. To identify a template with a 
more reactive S -0  bond, the presence o f an electron-withdrawing substituent on the 
phenol ring increased the reactivity, whereas the reactivity was attenuated with an 
electron-donating group. The effect o f sterics on the reactivity o f  the S -0  bond was also
I SQ
observed.
Scheme 23. Synthesis o f  chiral auxiliaries compound 27
It was envisioned that optically pure 27 could be efficiently accessed on large scale from 
the simple and commercially available chiral aminophenol 26. From compound 26 a 
variety o f  structurally diverse and sterically hindered alkyl and aryl sulfinamides were 
readily synthesized in high yields and e.r. values. The scope o f this chemistry was 
extended to the direct synthesis o f sterically hindered chiral sulfinyl ketimines (29) (in 
Scheme 24) by addition o f an imine nucleophile to the sulfinate ester 28. Sulfinyl 
ketimines are key intermediates in the synthesis o f chiral amine compound 30.
P y rid in e  
T H F , -3 0  °C , 1h
8 2 %26 27
Scheme 24. Synthesis o f chiral amines from compound 28
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i) P hC N , t-BuLi 
TH F, -78 °C , 1h NaBH,N H Ts
In conclusion, we obtained effective organo/hydrogelators based on D-glucose and D- 
glucosamine. We have also synthesized a variety o f  hinderd chiral sulfinmaides from the 
new chiral auxiliaries.
In the future the good organo/hydro gelators found in the current research can be 
explored for further applications in several systems: exploration o f their effectiveness in 
enzyme immobilization, designing analytical tools to understand molecular interactions, 
and as matrix for delivery o f biological agents, etc. By using the chiral auxiliary 27 the 
current research can be further explored to synthesize the new class o f chiral sulfoxides 
and can be used many other applications.
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